| Product |
Cat.# |
Incubation |
Stand. Range / Sensitivity |
Specimen |
Test Type |
| A |
|
|
|
|
|
| ACPA
(Anti-Citrullinated Protein Ab) Elisa |
EIA4848 |
30 / 15 / 15 min |
10 - 500 U/ml ** 2 U/mo |
10 ul setum, plasma |
quantitative |
| ACTH
(Adrenocorticotropic Hormone) |
EIA3647 |
4 hrs |
.46pg/mL |
human serum |
quantitative |
| Adenovirus
Ag (stool) |
EIA3444 |
30 / 5 / 5 / 5 min. |
pos. / neg. control ** 100% |
stool |
qualitative |
| Adenovirus
IgA |
EIA3445 |
60min 37C; 30 / 15 min. RT |
pos./ neg. / cut off control |
10 ul serum (1+100 diluted) |
qualitative |
| Adenovirus
IgG |
EIA3446 |
60 min. 37 C; 30 / 15 min. RT |
pos./ neg. / cut off control |
10 ul serum (1+100 diluted) |
qualitative |
| Adenovirus
IgM |
EIA3447 |
60 min. 37 C; 15 min RT |
pos. / neg. control |
10 ul serum (1+100 diluted) |
qualitative |
| Adipocyte
FABP (AFABP, FABP4) human Elisa |
EIA4908 |
60 / 60 / 30 / 10 min |
0.5 - 25 ng/ml **
<0.1 ng/ml |
20 ul serum, plasma |
quantitative |
| Adiponectin
(human) Elisa |
EIA4177 |
120/30/5-10 min |
1.56 - 200 ng/ml ** 0.78 ng/ml |
20 ul serum, plasma,
tissues culture media |
quantitative |
| Adiponectin
(human) Elisa |
EIA4574 |
120 / 10 min |
0.1 - 10 ug/ml **
7 ng/ml |
10 ul serum / plasma |
quantitative |
| Adiponectin
(human) Elisa |
EIA4646 |
60 / 60 / 15 min |
5 - 300 ng/ml **
1.25 ng/ml |
25 ul serum / plasma |
quantitative |
| Adiponectin
(human) Elisa |
EIA4820 |
90 / 30 / 20 min |
1.56 - 100 ng/ml **
<3 ng/ml |
5-10 ul cell culture supernatants,
plasma and serum |
quantitative |
| Adiponectin
(human) high molecular weight (HMW) |
EIA4645 |
120/60/30/5-20 min (sample prep
2h, 20 min) |
1.56 ng/ml to 200 ng/ml **
0.5 ng/ml |
20 ul serum, plasma, and adipocyte
extracts or cell culture media |
quantitative |
| Adiponectin
(mouse) Elisa |
EIA4172 |
120/30/15 min |
0.78 - 100 ng/ml ** 0.5 ng/ml |
10 ul serum, plasma, tissue
culture media (dilution 1:1000) |
quantitative |
| Adiponectin
Rat Elisa |
EIA4570 |
120 / 60 / 30 / 5 - 25 min |
3.125- 200 ng/ml **
0.155 ng/ml |
20 ul serum, plasma, nd adipocyte
extracts or cell culture media |
quantitative |
| Adrenalin
Research Elisa |
EIA4776 |
Acylation: 55 min, EIA: 30/120/30 min |
5 - 1280 pg/sample **
1.7 pg/sample |
1-100 ul, tissues extracts,
dialysates, small amounts of urine and plasma |
quantitative |
| Adrenaline
(Epinephrine) |
EIA1908 |
14-20 h/120/40 min. |
1,4-150 ng/ml |
75 ul urine/ Extr. &
Acylat. EXTRACTION POSSIBLE IN PLASMA |
quantitative |
| Adrenaline
/ Noradrenaline (Cat Combi Elisa) |
EIA4309 |
3.5 hours |
Epine. 1-256ng/ml, Norepine.
0/1-1,024ng |
plasma and urine |
quantitative |
| Adrenaline
Elisa |
EIA4306 |
3.5 hrs. |
1-256ng/ml ** urine 0.5 ng/ml; plasma 17pg/ml |
plasma, urine |
quantitative |
| Adrenomedullin,
(human) (1-52) |
EIA3418 |
|
|
|
quantitative |
| Adrenomedullin,
(Pro-) N20 (PAMP-20) (human) |
EIA3419 |
|
|
|
quantitative |
| AFP (Alpha
Fetoprotein) |
EIA1468 |
40 min. at RT |
10-160 ng/ml |
serum, amino fluid |
quantitative |
| AFP (Alpha
Fetoprotein) - extended Standard Range |
EIA4331 |
1 hr. at RT |
2.0 ng/ml |
serum |
quantitative |
| Akt
(total), (human, mouse, rat) |
EIA3996 |
120/60/30/30 min |
0.3 - 20 ng/ml / 0.1 ng/ml |
100 ul cell extract |
quantitative |
| Akt
[pS473], (human, mouse, rat) |
EIA3997 |
120/60/30/30 min |
1.6 - 100 U/ml /
0.8U/ml |
100 ul cell extract |
quantitative |
| Aldosterone |
CLA4650 |
60 / 10 min |
20 - 2000 pg/m **
10 pg/ml |
50 ul serum |
quantitative |
| Aldosterone
Elisa |
EIA4410 |
60 min. 37C / 30 min. RT |
20 - 2000 pg/ml **
15 pg/ml |
50 ul serum / plasma |
quantitative |
| Aldosterone
Elisa |
EIA4600 |
60/10-15 min |
20-2000 pg/ml **
15 pg/ml |
50 ul serum + urine |
quantitative |
| Aldosterone, direct |
EIA4128 |
60/20 min |
15 - 1000 pg/ml ** 10 pg/ml |
50 ul serum or diluted urine |
quantitative |
| AMA-M2 Elisa |
EIA3604 |
|
|
|
quantitative |
| Amphetamine |
EIA1493 |
45 min. at RT |
|
serum, plasma, blood |
quantitative |
| Amphetamine
Metabolites |
EIA2900 |
|
|
|
quantitative |
| Amylase
Elisa |
EIA4460 |
30 / 15 min |
10 - 300 U/L **
6 U/L |
10 uL serum |
quantitative |
| Amylin
(total) Elisa |
EIA3741 |
10 min. at RT/ 1h at RT shaking/
2h at RT shaking |
0-100pM / 1 pM |
50 ul plasma |
quantitative |
| Amylin
Elisa |
EIA3742 |
10 min. at RT/ 1h at RT shaking/
2h at RT shaking |
0-100pM / 1pM |
50 ul plasma |
quantitative |
| Amyloid A
(SAA) (human) serum |
EIA3783 |
2h |
18.75-300 ng/ml 5ng/ml |
50 ul |
quantitative |
| Amyloid A
(SAA) (mouse) serum |
EIA3784 |
2h |
233-3800 ng/ml 200ng/ml |
50 ul |
quantitative |
| Amyloid
beta 1-40 (colometric) |
COL3994 |
6.5 h |
|
|
quantitative |
| Amyloid
beta 1-42 (colometric) |
COL3995 |
6.5 h |
|
|
quantitative |
| Amyloid
Beta Auto-Ab Elisa |
EIA4914 |
1h / 30 + 20 min |
1 - 60 RTU **
< 1 RTU |
10 uL Serum / Immunoglobulin
samples |
quantitative |
| ANA
(Anti-Nuclear Antibodies) |
EIA4830 |
20/20/10 min. |
... **
95 % |
10 ul serum |
quantitative |
| ANA Screen
IgG (anti-nuclear antibodies) |
EIA2773 |
60, 30, 30 RT |
|
serum, 10 uL |
qualitative |
| ANA-8-Profile
Elisa |
EIA3563 |
|
|
|
quantitative |
| ANA-8-Profile
Elisa |
EIA4325 |
30 / 30 / 30 min. RT |
neg., pos. control **
<0.2 |
10 ul serum (diluted 1/100) |
qualitative |
| ANA-8-Screen
Elisa |
EIA3562 |
|
|
|
quantitative |
| ANCA
(cANCA) anti-PR3 |
EIA3596 |
|
|
|
quantitative |
| ANCA combi
"ANCA Profil" Elisa |
EIA3595 |
|
|
|
quantitative |
| ANCA Screen
Elisa |
EIA3776 |
30'/15'/15' RT |
qualitative, cut-off control |
serum or plasma 10 ul |
qualitative |
| ANCA Screen
IgG |
EIA2777 |
20, 20, 10 RT |
|
serum, 10uL |
qualitative |
| Androstane,
5a-Androstane-3a, 17beta-diol Glucuronide (3a Diol G) |
EIA4192 |
30/15 min |
0.25 - 50 ng/ml ** 0,1 ng/ml |
50 ul serum |
quantitative |
| Androstenedione
Elisa |
EIA3265 |
|
|
|
|
| Androstenedione
Saliva |
EIA4347 |
60 / 15 min. |
5 - 1000 pg/ml **
1pg/ml |
100 ul Saliva |
quantitative |
| Androstenedione
Saliva Elisa |
SLV4780 |
60 / 15 min |
20 - 1000 pg/mL **
5 pg/mL |
50 uL Saliva |
quantitative |
| Angiotensin
1 |
EIA1638 |
4 hrs. at RT |
0.1 ng/ml |
plasma |
quantitative |
| Angiotensin
2 |
EIA1526 |
|
0.2ng/mL |
|
quantitative |
| Animal
Insulin Control (3 vials /ea.0.5ml)<low,medium, high> |
CTL4784 |
|
|
|
|
| Annexin V
IgG/IgM, anti- |
EIA3971 |
13'/15'/15' RT |
6.3 - 100 U/ml **
1 U/ml |
10 ul serum or plasma |
quantitative |
| ANP, alpha-
(human) (Atrial Natriuretic Polypeptide ) |
EIA1524 |
|
0.2 ng/mL |
|
quantitative |
| Anti-Intrinsic
Factor Elisa |
EIA4392 |
30 / 15 / 15 min. |
6.3 - 100 U/mll **
1 U/ml |
10 ul serum / plasma |
quantitative |
| APO 1
(Apolipoprotein) /FAS/ CD05 (FAS) |
EIA3875 |
2h |
0.23-15ng/mL < 20 pg/mL |
100 ul serum |
quantitative |
| APO A
(Apolipoprotein) |
EIA1907 |
60/15 min. |
0.36-6.0 U/L |
25 ul serum |
quantitative |
| ASCA IgG, Elisa |
EIA4280 |
60 / 30 min. 37 C, 10 min RT |
20 - 300 U/ml ** 10 U/ml |
10 ul serum (1:51 diluted) |
quantitative |
| ASCA combi
Elisa |
EIA4278 |
60 / 30 min. 37 C, 10 min RT |
no qualitative eval. (compare w.
pos. ctrl) |
10 ul serum (1:51 diluted) |
qualitative |
| ASCA IgA
Elisa |
EIA4279 |
60 / 30 min. 37 C, 10 min RT |
20-300 U/ml ** 10 U/ml |
10 ul serum (1:51 diluted) |
quantitative |
| ASGPR -
Anti-ASGPR Elisa |
EIA4271 |
60 / 30 min. 37 C, 10 min RT |
pos. / neg. and cut off
control ** 0.3 (ratio) |
10 ul serum, plasma (1:51 diluted) |
qualitaitve |
| Aspergillus
fumigatus IgA |
EIA2500 |
|
|
|
|
| Aspergillus
fumigatus IgG |
EIA2501 |
60/30/20 min |
1-200
U/mL |
5 ul serum, plasma |
quantitative |
| Aspergillus
fumigatus IgM |
EIA2502 |
|
|
|
|
| Astrovirus
Ag (stool) Elisa |
EIA4456 |
60/10 min |
pos./neg. control **
96% |
stool specimen |
qualitative |
| Avian
Influenza A Nucleoprotein Ag Capture |
EIA4711 |
30/45/10 min on plate shaker |
pos + neg control ** <90%- **
<89% |
200 ul of complex sample matrices
derived from human/veterinary sources |
qualitative |
| Avian
Influenza A Nucleoprotein Ag Capture |
EIA4713 |
30/45/10 min on plae shaker |
pos + neg control **
<90% |
200 ul of complex sample matrices
derived from human/veterinary sources |
qualitative |
| Avian
Leukosis Virus-p27 antigen |
EIA2499 |
120/60/15 min. |
Positive and Negative Control |
100 ul egg or serum (1:1 diluted) |
|
| B |
|
|
|
|
|
| Barbiturates |
EIA1494 |
45 min. at RT |
|
serum, plasma, blood |
qualitative |
| Bax, human
Bax Elisa, (Bcl1 associated x protein) |
EIA4487 |
60 /60/30/30 min |
62.5 - 2,000 pg/mL **
10.1 pg/mL |
10 uL total cell lysates |
quantitative |
| Bcl-2, human Bcl-2 Elisa (B-cell lymphoma 2) |
EIA4488 |
60/60/30/30 min |
18.8 - 1,200 pg/mL **
3.8 pg/mL |
100 uL total cell lysates |
quantitative |
| BLV (Bovine
Leukemea Virus) p24 blockin AB, MCA based |
EIA3159 |
|
|
|
|
| BLV (Bovine
Leukemia Virus) p24/gp51 antibodies (milk) |
EIA2496 |
90/90/90/15 min. |
Positive and Negative Control |
100 ul milk (undiluted) |
|
| BLV (Bovine
Leukemia Virus) p24/gp51 antibodies (serum) |
EIA2495 |
90/90/60/15 min. |
Positive and Negative Control |
100 ul Serum (1:20 diluted) |
|
| BNP-32,
(rat) (Brain Natriuretic Peptide) EIA |
EIA3428 |
|
|
|
quantitative |
| Bordetella
pertussis IgA / toxin |
EIA3449 |
60min. 37 C; 15 RT |
pos./ neg. / cut off control |
10 ul serum (1+100 diluted) |
qualitative |
| Bordetella
pertussis IgG / toxin |
EIA3450 |
60 37 C; 30 / 15 min. RT |
pos./ neg. / cut off control |
10 ul serum (1+100 diluted) |
qualitative |
| Bordetella
pertussis IgM / toxin |
EIA3451 |
60min 37 C; 30 / 15 min. RT |
pos. / neg. control |
10 ul serum (1+100 diluted) |
qualitative |
| Borrelia
afzelii IgG (canine) Elisa |
EIA4687 |
30 / 15 / 10 min |
pos. + neg. control |
5 ul serum |
qualitative |
| Borrelia
afzelii IgG (equine) Elisa |
EIA4691 |
60 / 30 10 min |
pos. + neg. control |
5 ul serum |
qualitative |
| Borrelia
Blot IgG, (anti-Borrelia) |
DOT4539 |
5/45/3x5/45/3x5 min RT |
(comparison with charge specific
Blot pattern) |
20 ul serum (1:100 diluted) |
Blot strips |
| Borrelia
Blot IgM (anti-Borrelia) |
DOT4540 |
5/45/3x5/45/3x5 min RT |
(comparison with charge specific
Blot pattern) |
20 ul serum (1:100 diluted) |
strips |
| Borrelia
burgdorferi Canine Ab Elisa |
EIA4794 |
? |
neg. / pos. control |
serum and plasma |
qualitative |
| Borrelia
burgdorferi IgG (equine) Elisa |
EIA4692 |
60 / 30 / 10 min |
pos. and neg. control |
5ul serum |
qualitative |
| Borrelia burgdorferi IgG (Lyme) |
EIA2810 |
20, 20, 10 RT |
|
serum: 10uL |
qualitative |
| Borrelia
burgdorferi IgG Elisa |
EIA4486 |
30/30 min 37 C / 15 min RT |
pos. / neg. control ** 95 % |
10 ul serum |
qualitative |
| Borrelia
burgdorferi IgG/IgM (Lyme ) |
EIA2809 |
20, 20, 10 RT |
|
serum: 10uL |
qualitative |
| Borrelia burgdorferi IgM (Lyme
) |
EIA2811 |
20, 20, 10 RT |
|
serum: 10uL |
qualitative |
| Borrelia
burgdorferi IgM Elisa |
EIA4485 |
30/30 min 37C / 15 min. RT |
pos. / neg control /
90 % |
10 ul serum |
qualitative |
| Borrelia
IgG Elisa (recombinant) |
EIA4289 |
60/30 37 C; 30 min. RT |
pos. / neg, cut-off control |
10 ul serum (diluted 1:101) |
qualitative |
| Borrelia
IgM Elisa (recombinant) |
EIA4288 |
60/30 37 C; 30 min RT |
pos. / neg cut-off control |
10 ul serum (diluted 1:101) |
qualitative |
| BPI,
anti- Elisa |
EIA3598 |
|
|
|
quantitative |
| Bradykinin
(human - rat - mouse) |
EIA1639 |
4 hrs. at RT |
0.05 ng/ml |
plasma |
quantitative |
| Brucella
Ab, cattle |
EIA2497 |
|
Positive and Negative Control |
|
|
| Brucella IgA (human) |
EIA3271 |
60/30/20 min. at RT |
1 - 200 U/ml |
100 ul serum, plasma (1:100
diluted) |
quantitative |
| Brucella
IgG |
EIA3455 |
60 min 37C; 30 / 15 min. RT |
pos. / neg. control |
10 ul serum (1+100 diluted) |
qualitative |
| Brucella
IgM |
EIA3456 |
60 min. 37 C; 30 / 15 min. RT |
pos. / neg. control |
10 ul serum (1+100 diluted) |
qualitative |
| Buprenorphine |
EIA1498 |
45 min. at RT |
n/a |
serum, plasma, blood |
quantitative |
| C |
|
|
|
|
|
| C1q CIC
Elisa |
EIA3169 |
30/30/15 min. at 37 C |
2 Standards ( high/low),
concentration : 16y/ml |
100 ul diluted Serum, Plasma |
quantitative |
| C3bi CIC |
EIA3990 |
30/30/15 min |
0-64 ug/ml /
2ug/ml |
10 ul serum |
quantitative |
| C3d CIC
Elisa |
EIA3170 |
30/30/15 min. at 37 C |
2 Standards (high/low), human
aggregate IgG, |
100 ul diluted Serum, Plasma |
quantitative |
| C3d Elisa |
EIA2333 |
30/15/15 min. |
2 standards ( low and high) 2
controls |
100 ul serum (1:5 diluted) |
|
| C5a
(Anaphylatoxin/Complement Component) EIA |
EIA3327 |
20/15 min. at 37 C/ min. at RT |
Standard range: 0.1 - 10ug/L |
human plasma or urine |
quantitative |
| CA 125 |
EIA3939 |
50 / 30 min |
15 - 200 U/ml **
3.327 U/ml |
50 ul serum, plasma |
quantitative |
| CA 125
(Ovarian Cancer) Antigen |
EIA1472 |
3 hrs. at 37 C. |
5 U/ml |
serum |
quantitative |
| CA 15-3 |
EIA3941 |
60/30/30 min |
25-200 U/ml **
0.905 U/ml |
10 ul serum, plasma |
quantitative |
| CA 15-3
(Breast Cancer) Antigen (BCA) |
EIA1473 |
120 min. at 37 C. |
5 U/ml |
serum |
quantitative |
| CA 19-9 |
EIA3940 |
30 / 30 min |
15-240 U/ml /
0.888 U/ml |
10 ul serum, plasma |
quantitative |
| CA 19-9
(Gastrointestinal Cancer) Antigen (GCA) |
EIA1474 |
120 min. at 37 C. |
5 U/ml |
serum |
quantitative |
| CA 242 |
EIA2082 |
|
|
|
quantitative |
| CA 72-4 |
CLA4730 |
|
|
|
quantitative |
| CA 72-4 |
EIA3942 |
120/30 min. |
3-100 U/ml ** < 0.311 |
20 ul serum, plasma |
quantitative |
| CA-242 Elisa -
Pancreatic-colo-rectal |
EIA4581 |
120 / 60 / 30 min. |
5 - 200 U/ml **
1 U/ml |
25 ul serum |
quantitative |
| CagA |
EIA4138 |
60/30/15 min |
0-240 RU/ml **sensit. vs Western Blot: 93.7 % |
100 ul serum (1:300 diluted) |
qualitative |
| Calcitonin |
EIA3648 |
4 hrs |
1 pg / mL |
human serum |
quantitative |
| Calcitonin
(salmon) |
EIA1636 |
4 hrs. at RT |
0.2 ng/ml |
plasma |
quantitative |
| Calcitonin
Gene Related Peptide (CGRP)(Human) - EIA Kit |
EIA4513 |
2h / 1h/ 1h RT |
0 - 100 ng/ ml ** 0.23 ng/ml |
50 ul
plasma |
quantitative |
| Calprotectin
(MRP 8/14) Elisa |
EIA4498 |
60/60/60 37C / 10-20 min RT |
3.9 250 ng/ml **
2.9 ng/ml |
100 ul serum ( 1:50 dil.); urine
(1:10 dil.); |
quantitative |
| Candida
albicans IgA |
EIA3457 |
60 min 37 C; 30 / 15 min. RT |
pos. / neg. control |
10 ul serum (1+100 diluted) |
semi-quant |
| Candida
albicans IgG |
EIA3458 |
60 min 37 C; 30 / 15 min. RT |
pos./ neg. / cut off control |
10 ul serum (1+100 diluted) |
qualitative |
| Candida
albicans IgM |
EIA3459 |
60 min. 37 C; 30 / 15 min. RT |
pos. / neg. control |
10 ul serum (1+100 diluted) |
qualitative |
| Canine FSH
Elisa |
EIA4536 |
180 / 30 min |
0.78 - 25 ng/ml **
0.21 ng/ml |
25 ul serum / plasma |
quantitative |
| Cardiolipin
IgA |
EIA2790 |
20, 20, 10 RT. |
|
serum, 10uL |
semi-quant. |
| Cardiolipin IgG |
EIA2788 |
20, 20, 10 RT |
|
serum, 10uL |
semi-quant. |
| Cardiolipin
IgG/IgA/IgM |
EIA2635 |
|
|
|
quantitative |
| Cardiolipin
IgG/IgM anti- Elisa |
EIA3587 |
60' RT |
IgG:0-120 GPL-U/ml IgM:0-80 MPL-U/ml |
10 ul serum or plasma |
quantitative |
| Cardiolipin IgM |
EIA2789 |
20, 20, 10 RT |
|
serum, 10uL |
semi-quant. |
| Cardiolipin
Screen IgG/IgM anti- Elisa |
EIA3589 |
|
|
|
quantitative |
| CART
(Cocaine and Amphetamine RNA Transcript) Elisa |
EIA4427 |
2h / 1h/ 1h RT |
0-100
ng/ml |
50 ul plasma |
quantitative |
| Casein IgA
Elisa |
EIA4297 |
30 / 30 / 10 min. |
pos. and neg. control |
10 ul serum, plasma (1:100
diluted) |
qualitative |
| Casein IgG
Elisa |
EIA4298 |
30 / 30 / 10 min. |
pos. and neg. control |
10 ul serum, plasma (1:100
diluted) |
qualitative |
| Caspase-8
(human) Elisa |
EIA4863 |
2 hs / 1 hr / 20 min. at RT |
0.16 - 10 ng/mL **
0.10 ng/mL |
50 ul cell lysate, cell culture
supernatants, |
quantitative |
| Caspase-9
(human) Elisa |
EIA4860 |
2 hrs / 1 hr/ 20 min. at RT |
1.6 - 100 ng/mL **
0.4 ng/mL |
50 ul cell lysate, cell culture
supernatants, |
quantitative |
| Cat Combi
Research Elisa (Adren./Noradren.) |
EIA4892 |
90 min Aculation 2h 37C/15-20 h
2-8C |
0.45 - 45 ng/ml **
0.3/02 ng/ml |
1-750 uL; for various biological
sample types |
quantitative |
| Catcombi
Elisa (Adrenaline/Noradrenaline) |
EIA3175 |
120/90/15 min. at RT |
Adren.: 1.5 - 150 ul/ml,
Noradren.: 5 - 500 |
10 ul extracted plasma or urine |
quantitative |
| Catenin,
human Total beta-Catenin |
EIA4356 |
1h / 1 h/ 30 min / 30 min |
125 - 8000 pg/ml **
26.8 pg/ml |
100 ul diluted cell Lysate |
quantitative |
| Cathepsin
G, anti- Elisa |
EIA3600 |
|
|
|
quantitative |
| CAV (Canine
Adeno Virus) antibodies |
EIA2480 |
60/60/20 min |
Positive and Negative Control |
100 ul Serum (3-fold diluted, 1:30
- 1:810) |
|
| CCV (Canine
Corona Virus) IgG antibodies |
EIA2482 |
60/60/20 min. |
Positive and Negative Control |
100 ul Serum (3-fold diluted, 1:30
- 1:810) |
|
| CCV (Canine
Corona Virus) IgM antibodies |
EIA2483 |
60/60/20 min. |
Positive and Negative Control |
100 ul Serum (3-fold diluted, 1:30
- 1:810) |
|
| CD23
(soluble) Elisa |
EIA3874 |
2h/30min |
1 - 20 U/mL 0.15U/mL |
50 ul serum |
quantitative |
| CDV (Canine
Distemper Virus) IgG antibodies |
EIA2478 |
60/60/15 min. |
Positive and Negative Control |
100 ul Serum (3-fold diluted, 1:50
- 1:1350) |
|
| CDV (Canine
Distemper Virus) IgM antibodies |
EIA2479 |
60/60/15 min. |
Negative and Positive Control |
100 ul Serum (3-fold diluted, 1:30
- 1:810) |
|
| CEA |
EIA1868 |
60 / 15 min. |
0 - 100 ng/ml ** 0.44 ng/ml |
50 ul serum / plasma |
quantitative |
| CEA |
EIA1871 |
80 min. at RT |
1.0 ng/ml |
serum |
quantitative |
| Centromer
B, anti- Elisa |
EIA3569 |
|
|
|
quantitative |
| Ceruloplasmin
(rat) Elisa |
EIA4605 |
45 / 45 / 20 min |
11.7 - 750 ng/ml **
- |
2 ul serum / plasma |
quantitative |
| CETP
Activity (Cholesteryl ester transfer
protein) |
EIA4414 |
30 - 60 min 37 C |
zero standards |
1-3 ul serum / plasma |
qualitativ |
| CH 50 |
EIA3989 |
120/15 min |
controls qualitative |
50 ul serum |
qualitative |
| Chagas IgG
(Trypanosoma cruzy IgG) |
EIA3464 |
10 / 5 / 5 min. |
pos. / neg. control **
96% |
100 ul serum (diluted 1:64) |
qualitative |
| Chlamydia IgM (pneumoniae) |
EIA2941 |
|
|
|
qualitative |
| Chlamydia
(psittaci/trachomatis) Ab (cats only) |
EIA2474 |
50/60/10 min. |
Positive and Negative Control |
100 ul Serum (1:50 diluted) |
|
| Chlamydia
Brush Collection Kit (swabs for sample collection) |
EIA2513 |
|
|
|
|
| Chlamydia
IgA (pneumoniae) |
EIA2942 |
|
|
|
qualitative |
| Chlamydia
IgA (trachomatis) |
EIA3461 |
60 min 37 C; 30 / 15 min. RT |
pos. / neg. / cut off control |
10 ul serum (1+100 diluted) |
qualitative |
| Chlamydia
IgG (pneumoniae) |
EIA2940 |
|
|
|
qualitative |
| Chlamydia
IgG (pneumoniae) |
EIA3912 |
1 h 37 C / 30', 15' RT |
pos. + neg. control |
10 ul serum or plasma |
qualitative |
| Chlamydia
IgG (trachomatis) |
EIA3462 |
60 min. 37 C; 30 / 15 min. RT |
pos. / neg. / cut off control |
10 ul serum (1+100 diluted) |
qualitative |
| Chlamydia
IgM (pneumoniae) |
EIA3913 |
1 h 37 C / 30', 15' RT |
pos. + neg. control |
10 ul serum or plasma |
qualitative |
| Chlamydia
IgM (trachomatis) |
EIA3463 |
60 min. 37C; 30 / 15 min. RT |
pos. / neg. control |
10 ul serum (1+100 diluted) |
qualitative |
| Cholecystokinin
(CCK) (26-33) (nonsulfated) (human, rat, mouse) Elisa |
EIA4393 |
2h / 1h/ 1h RT |
0 - 100
ng / ml |
50 ul plasma |
quantitative |
| Chromoglycate |
EIA1500 |
45 min. at RT |
|
serum, plasma, blood |
quantitative |
| Chromogranin
A Elisa |
EIA4521 |
120/ 60 / 20 min |
31 - 830 ng/ml **
5 ng/ml |
25 ul serum |
quantitative |
| Chromogranin
A Elisa (CgA) |
EIA4479 |
overnight 90 / 30 min |
10 - 1000 fmol/ml **
/ |
25 uL saliva / plasma / urine |
quantitative |
| CHV (Canine
Herpes Virus) antibodies |
EIA2481 |
60/60/20 min. |
Positive and Negative Control |
100 ul Serum (3-fold diluted, 1:30
- 1:810) |
|
| CK-MB |
EIA4112 |
|
|
|
quantitative |
| Clostridium
diff. toxin A+B Ag (stool) |
EIA4203 |
30 / 5 / 5 min. |
pos.
/ neg. control |
stool |
qualitative |
| CMV IgG |
EIA1797 |
90 min at RT |
|
serum |
quantitative |
| CMV IgG
(Cytomegalovirus) |
EIA3468 |
60 min 37 C; 30 / 15 min. RT |
pos. / neg control |
10 ul serum (1+100 diluted) |
qualitative |
| CMV IgM |
EIA1796 |
90 min at RT |
|
serum |
quantitative |
| CMV IgM
(Cytomegalovirus) |
EIA3469 |
60 min 37C; 30 / 15 min RT |
pos. / neg. control |
10 ul serum (1+100 diluted) |
qualitative |
| Cocaine
(Benzoyl Ecgonine Metabolites) |
EIA1499 |
45 min. at RT |
|
urine |
quantitative |
| Complement
C3a des Arg, (human) Correlate EIA |
EIA3631 |
|
|
|
quantitative |
| Complement
C3a des Arg, (human) Correlate EIA |
EIA3641 |
|
|
|
quantitative |
| Complement
C4a des Arg, Correlate EIA |
EIA3632 |
|
|
|
quantitative |
| Complement
C4a des Arg, Correlate EIA |
EIA3642 |
|
|
|
quantitative |
| Corticosterone
Elisa |
EIA4164 |
60 / 15 min. |
0 - 240
nmol/l |
20 ul serum / plasma |
quantitative |
| Corticotropin
Releasing Factor (human - rat - mouse) |
EIA1631 |
4 hrs. at RT |
0.2-2.0 ng/ml |
plasma |
quantitative |
| Cortisol |
CLA4651 |
30 / 10 - 15 min |
0.5 - 60 ug/dL **
0.15 ug/dl |
20 ul serum |
quantitative |
| Cortisol
(human) |
EIA1887 |
1 hour @ RT |
2,5 ng/ml |
serum / plasma |
quantitative |
| Cortisol
(human) salivary |
SLV2930 |
60 / 30 min |
2000 - 80000 pg/ml **
1140 pg/ml |
100 ul saliva |
quantitative |
| Cortisol
(serum) CLA |
CLA4666 |
30 / 10 min |
20-800 ng/ml **
0.48 ng/ml |
20 ul serum |
quantitative |
| Cortisol
(urinary) EIA |
EIA2989 |
|
|
|
quantitative |
| Cortisol HS
salivary |
SLV4635 |
60/30 min |
0.1 - 30 ng/ml **
0.03 ng/ml |
100 ul saliva |
quantitative |
| Cortistatin-14
(rat) |
EIA3802 |
|
|
|
quantitative |
| Cotinine
(saliva) EIA |
EIA3243 |
30/30 min. |
5 - 50 ng/ml Cotinine (3
calibrators) |
Saliva samples |
semi-quant |
| Cotinine
(serum) EIA |
EIA3242 |
30/30 min. |
10 - 50 ng/ml |
serum or plasma samples |
semi-quant |
| Cotinine
(urine) EIA |
EIA1377 |
30/30 min. at RT |
neg/pos control |
urine |
qualitative |
| COX
Activity Kit (Cyclooxygenase) |
CLA4738 |
|
|
|
|
| Coxsackievirus
B5 IgG Elisa |
EIA4899 |
30/30/15 min |
... **
90 % pos+neg control |
10 ul serum, plasma |
qualitative |
| Coxsackievirus
B5 IgM Elisa |
EIA4900 |
30/30/15 min |
... **
90 % ps+neg control |
10 ul serum, plasma |
qualitative |
| C-Peptide |
EIA1293 |
270 min. at RT |
0.2-16 ng/ml |
serum, plasma, urine |
quantitative |
| C-Peptide
(human) |
EIA4262 |
60 / 60 / 15 min. |
95 - 3720 pmol/l ** 15 pmol/l |
25 ul serum, plasma or urine
(dilute urine samples 1/10) |
quantitative |
| C-Peptide
(rat) Elisa |
EIA4767 |
60 / 60 / 10 min |
100-4000 pmol/l **
< 100 pmol/l |
10 uL serum, plasma |
quantitative |
| CPV (canine
parvo virus) antigen Faeces |
EIA2477 |
50/50/15 min. |
Positive and Negative Control |
100 ul Serum (1:2 diluted) |
|
| CPV IgG
(canine parvo virus) antibodies Faeces |
EIA2475 |
60/60/60/15 min |
Positive and Negative Control |
100 ul Serum (3-fold diluted, 1:50
- 1:1350) |
|
| CPV IgM
(canine parvo virus) antibodies |
EIA2476 |
60/60/60/15 min |
Positive and Negative Control |
100 ul Serum (3-fold diluted, 1:50
- 1:1350) |
|
| CRP
(canine) Elisa |
EIA4694 |
30 / 30 / 10 min |
1.5 - 40 ug/mL **
3.6 ng/ml |
2 ul serum |
quantitative |
| CRP
(C-Reactive Protein) |
EIA1952 |
30/10/30 min. |
0-100 ug/ml 1ug/ml |
human serum and plasma |
quantitative |
| CRP (mouse)
Elisa |
EIA4823 |
60/30/5-10min |
1.56 - 25 ng/ml ** 2.5 ng/ml |
10 ul serum / plasma / fluids |
quantitative |
| CRP (rat)
Elisa |
EIA4695 |
30 / 30 5 - 10 min |
4.9 - 133.3 ul/mL **
2.5 ug/ml |
2 ul serum |
quantitative |
| CRP Elisa
(hs CRP) |
EIA4584 |
30 / 30 / 10 min |
0.4 - 10 ug/ml **
0.02 g/ml |
10 ul serum, plasma |
quantitative |
| CRP, HS
(C-Reactive Protein) |
EIA3954 |
|
|
|
quantitative |
| Cryptosporidium
Ag (stool) |
EIA3467 |
30 / 5 / 5 / 5 min. |
pos. / neg. control **
93 % |
stool |
qualitative |
| Cyclic AMP |
EIA2096 |
|
|
|
quantitative |
| Cyclic AMP
(direct) |
EIA3065 |
|
|
urine |
|
| Cyclic AMP
Parameter Assay Kit |
EIA3062 |
|
|
urine |
quantitative |
| Cyclic GMP |
EIA2097 |
|
|
|
quantitative |
| Cyclic GMP
(direct) |
EIA3069 |
|
|
|
quantitative |
| Cyclic GMP
Parameter Assay Kit |
EIA3067 |
|
|
|
quantitative |
| Cyfra 21-1 |
CLA4731 |
30 min. |
3 - 50 ng/ml **
0.03 ng/ml |
50 ul serum, heparin plasma |
qualitative |
| Cyfra 21-1
Elisa |
EIA3943 |
30 / 30 min |
3 - 50 ng/ml ** <0.266 ng/ml |
50 ul serum/plasma |
quantitative |
| Cystatin C
(human) Elisa |
EIA4394 |
30 / 30 / 5-10 min |
1 - 5000 ng/ml ** 0.02 ng/well |
10 ul serum and tissue culture
medium |
quantitative |
| Cysteinyl
Leukotriene correlate EIA |
EIA3615 |
|
|
|
quantitative |
| Cysteinyl
Leukotriene correlate EIA |
EIA3633 |
|
|
|
quantitative |
| Cysticercosis |
EIA2905 |
|
|
|
quantitative |
| Cytochrome
C Elisa |
EIA4490 |
60/60/30/45 min |
28.13 - 900 pg/mL **
6.03 pg/mL |
100 uL cell lysate |
quantitative |
| D |
|
|
|
|
|
| Dengue IgG |
EIA3470 |
60 min 37 C; 30 / 15 min. RT |
pos. / neg. control |
10ul serum (1+100 diluted) |
qualitative |
| Dengue IgM |
EIA3471 |
60 min 37 C; 30 / 15 min RT |
pos. / neg. control |
10 ul serum (1+100 diluted) |
qualitative |
| DHEA
(Dehydro-epiandrosterone) Elisa |
EIA3415 |
60/15 min. |
0-30 ng/ml |
20 ul serum |
quantitative |
| DHEA S
(Dehydro-epiandrosterone Sulphate) |
EIA1562 |
75 min. at RT |
0.1-10 ug/ml |
serum, plasma |
quantitative |
| DHEA
Salivary Elisa |
SLV3012 |
60/20 min |
10 - 1440 pg/mL **
3.3 pg/ml |
50 ul saliva |
quantitative |
| DHEA-S |
CLA4652 |
30 / 10 - 15 min |
0.02 - 10 ug/dL **
0.02 ug/dl |
25 ul serum |
quantitative |
| DHEA-S
(serum) CLA |
CLA4667 |
min. |
|
serum |
quantitative |
| DHEA-S
Saliva |
SLV4409 |
15 min. 37C / 15 min. RT |
0.2 - 12 ng/ml ** 25 pg/mL |
50 uL Saliva |
quantitative |
| Diabetes
Control Set (human Insulin) Low + High |
EIA2338 |
|
|
|
|
| Diabetes
Control Set (rat, porcine, sheep, bovine Insuline) Low + High |
EIA2746 |
|
|
|
|
| Diabetes-antigen Control (rat,
mouse) |
CTL4783 |
|
|
|
|
| Digoxin |
EIA3268 |
|
|
|
quantitative |
| Diol, 3
alpha diol G (5aAndrostone 3a17Bdiol Glucuronide) |
CLA4649 |
15 /15 min |
0.25 - 50 ng/ml **
0.1 ng/ml |
5 ul serum |
quantitative |
| Diphtheria
IgG Toxoid Ab (corynebacterium diphtheriae) |
EIA3466 |
10 / 5 / 5 min |
4 standards |
100 ul serum (diluted 1:100 and a
1:1,000 dil |
quantitative |
| Diphtheria
IgG, Elisa |
EIA2514 |
|
|
|
|
| DNA (ds)
anti- Antibody* |
EIA2574 |
|
Positive, negative Ctrl, positive
calib |
|
|
| DNA (ds)
IgA, anti- Elisa |
EIA3565 |
|
|
|
quantitative |
| DNA (ds)
IgG |
EIA2774 |
20, 20, 10 RT. |
|
10 uL serum |
semi-quant. |
| DNA (ds)
IgM, anti Elisa |
EIA3564 |
|
|
|
quantitative |
| DNA (ds)
Screen, anti- Elisa |
EIA3566 |
30 / 15 / 15 min |
12.5 - 200 U/ml **
1U/ml |
10 ul serum / plasma |
quantitative |
| DNA (ss)
anti- Elisa |
EIA3567 |
|
|
|
|
| Dopamin
Research ElisA |
EIA4824 |
30 / 120 / 30 / 30 min |
25 - 6,400 pg/sample **
8.3 pg/sample |
1-100 uL tissues homogenates,
dialysates and other ultra small sample volumes |
quantitative |
| Dopamine
Elisa |
EIA4161 |
30 min 37 C, 120, 30, 40-45 min RT |
0 - 3840 ng/ml ** 7.5 ng/ml urin,
12.5 pg/ml plasm |
600 ul plasma o. 10 ul urine |
quantitative |
| Dopamine
Elisa |
EIA4615 |
120/60/40 min |
12-2250 ng/mL **
urin 5 ng/mL; plasma 4 pg/ml |
500 uL plasma, 20 uL urine |
quantitative |
| DR4 (human)
Elisa |
EIA3998 |
120/60/30/30 min. |
39 - 2500 pg/ml / <14 pg/ml |
100 ul cell extract |
quantitative |
| DR5 (human)
Elisa |
EIA4008 |
120/60/30/30 min |
70 - 500 pg/ml = quant. /
<15 pg/ml |
100 ul cell extract |
quantitative |
| E |
|
|
|
|
|
| E. coli
0157 (EHEC) Ag (stool) |
EIA4229 |
30/30/10 min. |
pos. / neg. control **
92 % |
stool |
qualitative |
| E. Coli
Verotoxin 1+2 Ag (stool) Elisa |
EIA4452 |
60/30/30/15 min |
pos./neg. control ** 84.6 % |
stool speciment |
qualitative |
| E. Coli
Verotoxin Ag (stool) |
EIA4204 |
30 / 30 / 30 / 10 min |
pos. / neg. control **
86 % |
stool |
qualitative |
| Echinococcus
granulosus IgG |
EIA3472 |
10 / 5 / 5 min. |
pos./ neg. / cut off control
/ 97.8 % |
100 ul serum (diluted 1:64) |
qualitative |
| Echovirus
IgG Elisa |
EIA4909 |
30/ 30/ 15 min |
pos. + neg. control **
90 % |
10 ul serum, Plasma |
qualitative |
| Echovirus
IgM Elisa |
EIA4910 |
30 / 30 / 15 min |
pos. + neg. control **
90 % |
10 ul serum, plasma |
qualitative |
| EGF (human)
(Epidermal Growth Factor) |
EIA1734 |
3 hrs. at RT |
0.5 ng/ml |
Urine |
quantitative |
| Ehrlichia
canis IgG (canine) Elisa |
EIA4689 |
15 / 15 / 10 min. |
pos and neg. control |
5 ul serum |
qualitative |
| Ehrlichia
equi IgG (canine) Elisa |
EIA4688 |
30/15/10 min |
pos and neg. control |
5 ul serum |
qualitative |
| Ehrlichia
equi IgG (equine) Elisa |
EIA4693 |
60 / 30 10 min |
pos. and neg. control |
5 ul serum |
qualitative |
| ENA Combi |
EIA3572 |
|
|
|
quantitative |
| ENA Screen
(entractable nuclear antigen) |
EIA2779 |
20, 20, 10 RT |
|
serum, 10 uL |
semi-quant. |
| ENA-4-Profile
Elisa |
EIA3977 |
30'/15'/15'/15'/5' |
qualitative, cut-off OD Quotient |
10 ul serum or plasma |
qualitative |
| ENA-6-Profile |
EIA2780 |
20, 20, 10 RT |
|
serum, 50 uL |
semi-quant. |
| ENA-6-Profile |
EIA3901 |
30' RT |
Qualt., Cut-off OD-Quotient |
10 ul Serum or Plasma |
qualitative |
| ENA-6-Screen |
EIA3571 |
|
|
|
quantitative |
| Endothelin
1 |
EIA3111 |
|
|
|
quantitative |
| Endothelin
1 (Big) (rat) TiterZyme EIA |
EIA3617 |
|
|
|
quantitative |
| Endothelin
1 (Big) , human |
EIA3110 |
|
|
|
quantitative |
| Endothelin
2 (ET-2) (human - canine) |
EIA3421 |
|
|
|
quantitative |
| Endothelin-1
(H - R - M - B - P - C - R) |
EIA3420 |
|
|
|
quantitative |
| Entamoeba
histolytica Ag (stool) |
EIA3473 |
30 / 5 / 5 / 5 min. |
pos. / neg. control ** 88 % |
stool |
qualitative |
| Entamoeba
histolytica IgG (Amebiasis) Elisa |
EIA3474 |
10 / 5 / 5 min. |
pos. / neg. control ** 92 % |
100 ul serum (diluted 1:64) |
qualitative |
| Enterovirus
IgG Elisa |
EIA4901 |
30/30/15 min |
... **
91.6 % pos+neg control |
10 ul serum, plasma |
qualitative |
| Enterovirus
IgM Elisa |
EIA4902 |
30/30/15 min |
... **
91.6 % |
10 ul serum, plasma |
qualitative |
| Epstein
Barr Virus (EBV-EBNA) IgG |
EIA4246 |
60 37 C; 30 / 15 min RT |
pos. / neg. control |
10 ul serum (1+100 diluted) |
qualitative |
| Epstein
Barr Virus (EBV-EBNA) IgM |
EIA4247 |
60 37 C; 30 / 15 min. RT |
pos. / neg. control |
10 ul serum (1+100 diluted) |
qualitative |
| Epstein
Barr Virus (EBV-VCA) IgG |
EIA3475 |
60 37 C; 30 / 15 min RT |
pos./ neg. / cut off control |
10 ul serum (1+100 diluted) |
qualitative |
| Epstein
Barr Virus (EBV-VCA) IgM |
EIA3476 |
60 37C; 30 / 15 min RT |
pos./ neg. / cut off control |
10 ul serum (1+100 diluted) |
qualitative |
| Epstein
Barr Virus EA IgG |
EIA2796 |
20, 20, 10 RT |
|
serum, 10uL |
qualitative |
| Epstein
Barr Virus EA IgM*, Elisa |
EIA2518 |
|
|
|
|
| Epstein
Barr Virus EBNA IgA*, Elisa |
EIA2519 |
|
|
|
|
| Epstein
Barr Virus EBNA IgG |
EIA4052 |
1 h / 30 min / 15 min |
negative / positiv control |
10 ul serum |
qualitative |
| Epstein
Barr Virus EBNA-1 IgG |
EIA2795 |
20, 20, 10 RT |
|
serum, 10uL |
qualitative |
| Epstein
Barr Virus VCA IgG |
EIA2793 |
20, 20, 10 RT |
|
serum, 10uL |
qualitative |
| Epstein
Barr Virus VCA IgM |
EIA2794 |
20, 20, 10 RT |
|
serum, 10uL |
qualitative |
| ERK 1/2
(total) |
EIA3999 |
120/60/30/30 min |
31.2 - 2000 pg/ml / 16pg/ml |
100 ul cell extract |
quantitative |
| ERK 1/2
(total) Elisa |
EIA4567 |
1 h/ 1 h/ 30 min |
156; 312; 625; 1.250; 2.500;
5.000; 10.000; 20.000 |
100 ul cell lysate |
quantitative |
| ERK 1/2
[pTpY185/187] Elisa |
EIA4000 |
120/60/30/30 min |
1.6 - 100 U/ml /
1.0 U/ml |
100 ul cell extract |
quantitative |
| Erythropoietin
(Epo) - single-step sandwich assay - |
EIA3646 |
16 - 20 hrs |
6mU/mL |
human serum |
quantitative |
| Estradiol |
EIA2693 |
2 hrs at RT |
0 / 4.6pg/ml |
serum, plasma |
quantitative |
| Estradiol
(serum) CLA |
CLA4664 |
min |
|
serum |
quantitative |
| Estradiol
Saliva (E2) |
SLV4188 |
120/15 min. |
0.1 - 100 pg/ml ** 0.085 pg/ml |
100ul saliva |
quantitative |
| Estradiol
US (ultra sensitive) |
EIA4399 |
4 h / 30 min. |
3 - 200 pg/ml ** < 1pg/ml |
100 ul serum, plasma |
quantitative |
| Estradiol,
17-beta |
EIA3125 |
|
|
|
quantitative |
| Estradiol,
17-beta |
EIA4352 |
|
|
human serum or plasma |
quantitative |
| Estriol
(E3), Free |
EIA1612 |
90 min. at RT |
1-40 ng/ml |
serum |
quantitative |
| Estriol
Saliva |
CLA4653 |
45 / 20 / 10 - 15 min |
0.1 - 100 pg/ml **
0.7 pg/ml |
50 ul saliva |
quantitative |
| Estriol,
Free (saliva) |
SLV3653 |
60 min. 37 C / 15 min RT |
0.1 - 12 ng/ml **
2 pg/ml |
20 ul Saliva |
quantitative |
| Estriol,
total |
EIA3717 |
1 h 15 min. |
2,0 - 200,0 ng/ml / 40
pg |
20 ul |
quantitative |
| Estrone |
EIA4079 |
1 hr. |
|
|
|
| Estrone
Elisa |
EIA4174 |
60/30 min. |
15 - 2000 pg/ml ** 6,3 pg/ml |
50 ul Serumin research |
quantitative |
| Estrone
Saliva |
CLA4655 |
60 / 30 / 10 - 15 min |
2 - 800 pg/ml **
1.0 pg/ml |
100 ul saliva |
quantitative |
| Estrone
Serum |
CLA4654 |
30 / 10 - 15 min |
15 - 2000 pg/ml **
8.8 pg/ml |
50 ul serum |
quantitative |
| F |
|
|
|
|
|
| FABP, human
(Fatty Acid Binding Protein) |
EIA4412 |
60 / 20 min. |
1 - 100
ng/ml |
100 ul serum |
quantitative |
| Fasciola
Hepatica (bovine) Elisa |
EIA4324 |
60/60 min 37C; 10 min RT |
pos., sample : qualitative test |
10 ul bovine serum |
qualitative |
| Fasciola
Hepatica IgG (human) Elisa |
EIA4503 |
60 37 C; 30 / 15 min RT |
pos. / neg. / cut off control |
10 ul serum (1+100 diluted) |
qualitative |
| FCoV Ab
(indication for FIP disease) |
EIA2468 |
60/60/20 min |
Positive and Negative Control |
100 ul Serum ( 3-fold diluted,
1:30 - 1:810) |
|
| FCV (Feline
Callici Virus) antibodies |
EIA2473 |
60/60/60/15 min. |
Positive and Negative Control |
100 ul Serum (3-fold diluted, 1:30
- 1-810) |
|
| FeLV-gp70
(Feline Leukemia Virus-GP70) antibodies, virus coated |
EIA2470 |
90/60/75/15 min. |
Positive and Negative Control |
100 ul Serum (3-fold diluted, 1:30
- 1:810) |
|
| FeLV-p27
(Feline Leukemia Virus) antigen |
EIA2469 |
20/20/15 min |
Positive and Negative Control |
50 ul Serum (dilution 1:1) |
|
| Fentanil |
EIA1504 |
45 min. at RT |
|
serum, plasma, blood |
quantitative |
| Ferritin |
EIA1872 |
80 min. at RT |
5.0 ng/ml |
serum |
quantitative |
| Ferritin
Elisa |
EIA4292 |
30 / 15 / 15 min. |
15 - 1500 ng/ml **
5ng/ml |
25 ul serum, plasma |
quantitative |
| Ferritin
Elisa |
EIA4408 |
60 / 10 min |
5 - 100 ng/ml **
1.0 ng/ml |
20 uL serum / plasma |
quantitative |
| Fetuin A
Elisa |
EIA4522 |
120/ 30 / 20 min |
12.5 - 370 ng/ml **
5 ng/ml |
25 ul diluted serum, Tissues
extracts |
quantitative |
| FGF-23
(Fibrolast growth factor 23) (human intact) |
EIA4737 |
3 h / 30 min |
6-650 pg/mL **
1.0 pg/mL |
150 uL plasma or cell culture
media |
quantitative |
| FHV (Feline
Herpes Virus) antibodies |
EIA2472 |
60/60/15 min. |
Positive and Negative Control |
100 ul Serum (3-fold diluted, 1:30
- 1:810) |
|
| Fibronectin,
(human) |
EIA1736 |
3 hrs. at 37 C. |
|
Biological sample |
quantitative |
| FIV p24/p17
(Feline Immunodeficiency Virus) Ab |
EIA2463 |
45/50/10 min |
Positive and Negative Control |
100 ul serum (1:100 diluted) |
|
| Fodrin,
anti-alpha-Fodrin |
EIA3978 |
|
|
|
|
| Food
Additives Allergy Screening Elisa |
EIA4725 |
60 / 30 / 10 min |
50 - 400
U/ml |
25 uL serum |
quantitative |
| Food
Allergies IgG - Allerquant 90G |
EIA1745 |
overnight at 2-8 C |
|
serum |
quantitative |
| FPV (Feline
Panleucopenia Virus = Felepine Parvo Virus) Ab EIA |
EIA2467 |
60/60/60/10 min. |
Positive and Negative Control |
100 ul Serum (3-fold diluted, 1:50
- 1:1350) |
|
| FPV (Feline
Panleukopenia Virus = Feline Parvo Virus) ag EIA |
EIA2466 |
50/60/15 min. at 37 C |
Positive and Negative Control |
100 ul Faeces (1:2 diluted) |
qualitative |
| FSH
(Follicle Stimulating Hormone) |
EIA1288 |
40 min. at RT |
5-100 mIU/ml |
serum |
quantitative |
| FSH
(Follicle Stimulating Hormone) |
EIA1785 |
1 hr. at RT |
2.5 mIU/ml |
serum |
quantitative |
| FSME (TBE)
IgG, Elisa |
EIA2525 |
|
|
|
|
| G |
|
|
|
|
|
| GAD-65,
anti EIA |
EIA1910 |
150 min RT |
-
** 85 % |
serum |
qualitative |
| Galactose
(with Membrane Plate) |
EIA1488 |
90 min. at RT |
<1.5 mg/dL |
blood |
quantitative |
| Galactose
(without Membrane Plate) |
EIA1489 |
90 min at RT |
<1.5 mg/dL |
blood |
quantitative |
| Galactose
neonatal (with Membrane Plate) |
EIA1486 |
90 min. at RT |
< 1.5 mg/dL |
blood |
quantitative |
| Galactose
neonatal (without Membrane Plate) |
EIA1487 |
90 min at RT |
<1.5 mg/dL |
blood |
quantitative |
| Galectin-3
(human) Elisa |
EIA4858 |
2 hrs / 1 hr/ 10 min. at RT |
0.39 - 25.0 ng/mL **
0.12 ng/mL |
50 ul cell culture, serum, plasma
other biol. |
quantitative |
| Gardenella
Vaginalis IgA Elisa |
EIA4516 |
60 / 60 / 15 min. |
-
/ / |
10 ul serum / vaginal liquid |
qualitative |
| Gardenella
Vaginalis IgG Elisa |
EIA4515 |
60 / 60 / 15 min |
-
/ - |
10 ul serum / vaginal liquid |
quantitative |
| Gardnerella
Vaginalis IgM Elisa |
EIA4514 |
60 / 60 / 15 min |
-
/ - |
10 ul serum / vaginal liquid |
qualitative |
| Gastrin
(human) |
EIA4187 |
2 / 3 hrs |
39.1 - 10000 pg/mL / 7.27 pg/mL |
100 uL serum |
quantitative |
| Gastrin 1
(human) EIA |
EIA3266 |
|
|
|
quantitative |
| Gastrin 1
(rat) (1-17) Elisa |
EIA4501 |
2 h RT / 3 h 37C |
78.1 - 5000 pg/mL **
78.1 pg/mL |
50 uL tissue culture media, EDTA
plasma, seru |
quantitative |
| Gastrin
Inhibitor Peptide (human) (GIP) |
EIA4142 |
2/1/1 hours |
0.41-3.12 ng/ml **
0.41 ng/ml |
50 ul plasma, serum, culture
media, tissue ho |
quantitative |
| Gastrin
Inhibitor Peptide (human) (GIP) Elisa |
EIA4527 |
90/60/30/20 min |
8.2 - 2000 pg/ml **
8.2 pg/ml |
20 ul serum, plasma, tissue
extract and cell |
quantitative |
| Gastrin
Inhibitor Peptide (rat/mouse) (GIP) Elisa |
EIA4528 |
90/60/30/18 min |
8.2 - 2000 pg/ml **
8.2 pg/ml |
10 ul serum, plasma, tissue
extract and cell |
quantitative |
| GBM,
anti- Elisa |
EIA3603 |
|
|
|
quantitative |
| G-CSF
(Granulocyte-Colony Stimulating Factor) |
EIA3876 |
4h |
39
- 2500 pg/mL <20 pg/mL |
50 ul |
quantitative |
| Ghrelin
(active) human Elisa |
EIA4710 |
120/30/15 min. at RT |
25 - 2000 pg/mL **
8 pg/mL |
20 ul serum or plasma |
quantitative |
| Ghrelin
(acylated) human Elisa |
EIA4686 |
3h / 30-60 min |
1.96 - 250 pg/ml ** 4 pg/ml |
100 uL (1:5 diluted) EDTA plasma
o. butter solution |
quantitative |
| Ghrelin
(human) |
EIA3706 |
|
|
|
quantitative |
| Ghrelin
(rat - mouse) |
EIA3707 |
|
|
|
quantitative |
| Ghrelin
(total) human Elisa |
EIA4709 |
120/30/25 min. at RT |
100 - 5000 pg/mL **
30 pg/mL |
20 uL serum or plasma |
quantitative |
| Giardia
lamblia Ag (stool) |
EIA3477 |
30 / 5 / 5 / 5 min. |
pos. / neg. control ** 5-10 ng/ml |
stool |
qualitative |
| Gliadin IgA |
EIA3370 |
|
|
|
qualitative |
| Gliadin IgG |
EIA3371 |
|
|
|
qualitative |
| Gliadin
IgG, anti- Elisa |
EIA3605 |
|
|
|
quantitative |
| Gliadin IgM, Elisa |
EIA2528 |
|
|
|
|
| Gliadin
Screen, (Anti-Gliadin) Elisa |
EIA4465 |
30 / 15 / 15 min |
6.3 - 100 U/ml **
1 U/ml |
10 ul serum / plasma |
quantitative |
| Glicentin
(rat) Elisa |
EIA4477 |
15 - 18 h / 60/30 min |
0.206 - 50 pmol/ml ** - |
30 uL plasma |
quantitative |
| Glucagon
(rat, mouse, human) Elisa |
EIA4475 |
overnight 4 C / 60 / 20 min RT |
50 - 10000 pg/ml **
/ |
50/100 uL plasma |
quantitative |
| Glucagon
like Peptide (GLP-2) mouse Elisa |
EIA4476 |
overnight 4 C / 60/30 min RT |
0.412 - 100 ng/ml **
- |
25 uL plasma, serum |
quantitative |
| Glucagon
like Peptide (GLP-2) rat Elisa |
EIA4478 |
overnight 4 C / 60/30 min RT |
0.137 - 100 ng/ml **
- |
25 uL plasma, serum |
quantitative |
| Glucagon
like Peptide (GLP-2), human, Elisa |
EIA4474 |
overnight 4C / 60/30 min RT |
0.137 - 100 ng/ml **
/ |
25 uL plasma |
quantitative |
| Glucagon
Like Peptide 1 (active) |
EIA3056 |
|
|
|
quantitative |
| Glucagon
Like Peptide 1 (GLP-1) (7-26) Amide (human - rat - mouse) |
EIA4141 |
|
|
|
quantitative |
| Glycodelin
(PP14) Elisa |
EIA3779 |
|
|
|
quantitative |
| Glycoprotein
1 IgG/IgM, anti-beta2 Elisa |
EIA3590 |
|
|
|
quantitative |
| Glycopyrrolate |
EIA1505 |
45 min. at RT |
|
serum, plasma, blood |
quantitative |
| Glykoprotein
1 IgA, anti beta 2 - |
EIA3884 |
60' RT |
0 - 100 U/ml, 0.5U/ml |
10 ul serum or plasma |
quantitative |
| Glykoprotein
1 Screen, anti beta 2 |
EIA3911 |
30' / 15' / 15' RT |
Neg., cut-off, Pos., Strong Pos
Ctrl. / 0.5 U/ml |
10 ul serum or plasma |
qualitative |
| GM-CSF
(Granulocyte Macrophage-Colony Stimulating Factor) |
EIA3877 |
2h / 30 min |
3.9 - 250 pg/mL < 1.25 pg/mL |
50 ul |
quantitative |
| GM-CSF
(human) Elisa |
EIA4859 |
3 hrs / 10 min |
8 - 500 pg/mL **
2.9 pg/mL |
50 ul cell culture, serum50 ul
cell culture, serum, plasma, amniotic fluid |
quantitative |
| GM-CSF
(mouse) (Granulocyte Macrophage Colony Stimu Factor) EIA |
EIA3416 |
4 hours |
7.8-500 pg/ml |
50 ul serum, tissue culture
supernatant |
quantitative |
| GM-CSF
(mouse) (Granulocyte Macrophage Colony Stimu Factor) EIA |
EIA3417 |
4 hours |
7.8-500 pg/ml |
50 ul serum, tissue culture
supernatant |
quantitative |
| GRO/CINC 1,
(rat) TiterZyme EIA |
EIA3618 |
|
|
|
quantitative |
| Growth
Hormone (Rat/Mouse) Elisa |
EIA4614 |
90/60/30/20 min |
0.21 - 50 ng/ml **
0.07 ng/ml |
10 ul rat or mouse serum, plasma,
tissue extracts or cell culture media samples |
quantitative |
| Growth
Hormone Releasing Factor (human) EIA |
EIA3429 |
|
|
|
quantitative |
| Guinea Pig
IgE Elisa |
EIA4462 |
10/60/30/30 min. |
3.1-800 ng/ml **
- |
15 ul guinea pig serum or plasma |
quantitative |
| H |
|
|
|
|
|
| H. Pylori Ag (stool) Elisa |
EIA4354 |
120/20 min. at 37 C |
0.1 - 1.0
ul/ml |
~ 0.2 grams |
quantitative |
| H. Pylori Ag Stool Extraction
Kit |
EIA4355 |
|
|
|
|
| H. Pylori
IgA |
EIA3483 |
60 min 37 C; 30 / 15 min. RT |
pos. / neg. control |
10 ul serum (1+100 diluted) |
qualitative |
| H. Pylori
IgA, anti- (qualitative) |
EIA4099 |
|
|
|
qualitative |
| H. Pylori
IgG |
EIA3484 |
60 min 37 C; 30 / 15 min. RT |
pos / neg. control |
10 ul serum (1+100 diluted) |
qualitative |
| H. Pylori
IgG (Gastritus & Peptic Ulcer) qualitative |
EIA1791 |
1.5 hrs. at RT |
98% |
serum |
qualitative |
| H. Pylori
IgG (Gastritus & peptic Ulcer) quantitative |
EIA3057 |
|
|
|
quantitative |
| H. Pylori
IgG (ref. sera opt., price on req.) |
EIA2815 |
20, 20, 10 RT |
|
serum: 10uL |
qualitative |
| H. Pylori
IgG, anti- (Gastritus & Peptic Ulcer) qualitative |
EIA4100 |
|
|
|
qualitative |
| H. Pylori
IgM (qualitative) |
EIA2111 |
|
|
|
qualitative |
| H. Pylori
IgM, anti- (qualitative) |
EIA4101 |
|
|
|
qualitative |
| Haemophilus
influenzae IgG, Elisa |
EIA2530 |
60 / 60 / 30 min. |
--- **
9,1yg.nk |
20ul serum, citrate-, EDTA- or
Heparin Plasma |
quantitative |
| HAMA Elisa
(human anti-mouse Ab) Magiwel |
EIA4195 |
30/15 min |
25 - 1000 ng/ml / - |
25 ul diluted serum samples
(1:101) |
quantitative |
| HAMA IgG
Elisa |
EIA1898 |
|
|
|
quantitative |
| HAV Ab |
EIA4233 |
60/60 min. 37 C, 20 min. RT |
nev. / pos. control **
100 %] |
100 ul serum, plasma (human) |
qualitative |
| HAV IgM (capture) Elisa |
EIA4432 |
60 / 60 min 37 C/20 min RT |
pos. / neg. control /
99% |
10 ul serum, plasma |
qualitative |
| HAV IgM,
anti- (ELISA) |
EIA3889 |
|
|
|
qualitative |
| HBc Ab
(Screening) Elisa |
EIA4872 |
60/60 min 37C / 20 min RT |
-
** 94.9 % |
50 uL serum, plasma |
qualitative |
| HBc Ab screening Elisa |
EIA4086 |
60/60 at 37C, 20 min. RT |
neg., pos., control, qualitative |
50 ul serum, plasma |
qualitative |
| HBc IgM Elisa |
EIA4085 |
60/60 at 37C, 20 min. RT |
0-100 PEI U/ml /
100 % |
10 ul serum, plasma |
quantitative |
| HBc IgM,
anti-(ELIZA) |
EIA3895 |
|
|
|
qualitative |
| HBc, anti-
(ELISA) |
EIA3894 |
|
|
|
qualitative |
| HBe, anti-
(ELISA) |
EIA3891 |
|
|
|
qualitative |
| HBeAg (ELISA) |
EIA3890 |
|
|
|
qualitative |
| HbeAg/Ab Elisa |
EIA4162 |
60/60 at 37 C, 20 min RT |
neg., pos. control,
qualitative / 0.5 PEI U/ml |
50 ul serum |
qualitative |
| HBs Ab Elisa |
EIA4135 |
60/60' 37C, 20' RT |
0-500 WHO mlU/ml ** 5 WHO mlU/ml |
100 ul serum, plasma |
quantitative |
| HBs,
anti- (ELISA) |
EIA3893 |
|
|
|
qualitative |
| HBsAg |
EIA3918 |
1 h/ 30' at RT, 30' at RT |
qualitative / 0.125 U/ml |
100 ul serum or Plasma |
qualitative |
| HBsAg (ELISA) |
EIA3892 |
|
|
|
qualitative |
| HCG
(total), beta (human serum) |
EIA1911 |
60/15 min. |
5-200 mlU/ml |
25 ul serum |
quantitative |
| HCG
(total), human serum only (human chorionic Gonadotropin) |
EIA1469 |
40 min. at RT |
std. range 5 - 1000 mIU/ml |
serum |
quantitative |
| HCG
(visual) Elisa |
EIA2113 |
|
|
|
qualitative |
| hCG beta
(beta-human Chorionic Gonadotropin) |
EIA4115 |
|
|
|
quantitative |
| hCG beta,
free Elisa |
EIA4718 |
30 / 30 / 20 min |
2.5-50 ng/ml **
0.196 ng/ml |
50 ul serum |
quantitative |
| HCG
Intact Elisa (serum) |
EIA1783 |
1 hr. at RT |
2.0 mIU/ml |
serum |
quantitative |
| HCV AB |
EIA3903 |
45'/45' 37C, 15' RT /
>98% |
neg. / pos. control, qualt. |
10 ul serum, plasma (human) |
qualitative |
| HCV
anti- (ELISA) 3rd generation |
EIA3896 |
|
|
|
qualitative |
| HCV IgG
(4th generation Synthetic Ag) |
EIA3482 |
60 min 37 C; 30 / 15 min RT |
pos. / neg. / cut off control |
10 ul serum (1+100 diluted) |
qualitative |
| HDV Ab Elisa |
EIA4269 |
90' 37C, 20' RT |
negative + positive control |
50 ul serum, plasma |
qualitative |
| HDV Ag Elisa |
EIA4268 |
120'/60 37 C, 20' RT |
negative + positiv control |
100 ul serum, plasma |
qualitative |
| Heartworm
Ag Canine Elisa |
EIA4795 |
? |
neg. / pos. control |
seum and plasma |
qualitative |
| HepAK Dot |
DOT4274 |
30/30/10-12 min. RT (+30 min
drying) |
compare with pos Dot cont |
10 ul serum, plasma |
pos. dot ctrl |
| HepAK plus
Dot |
DOT4275 |
30/30/10-12 min. RT (+30 min.
drying) |
compare w. pos. Dot control |
10 ul serum, plasma |
pos. dot ctrl |
| Hepatocyte
Growth Factor (human) (HGF) |
EIA3791 |
3h |
156-10,000 pg/ml < 19 og.nk |
50 ul |
quantitative |
| Hepcidin
Elisa (C-terminal) |
EIA4705 |
1/3h / 30/20min |
0-111 ng/ml **
0,49 ng/ml |
200 ul serum / plasma |
quantitative |
| Hepcidin
Prohormone (EIA4015) Elisa |
EIA4644 |
120 / 60 / 30 min |
10 - 1000 ng/ml ** 3.95 ng/ml |
50 ul serum |
quantitative |
| HETE-12
(12(S)-HETE TiterZyme) |
EIA1584 |
overnight at 2-8 C |
0.25-50 ng/ml |
EDTA-plasma |
quantitative |
| HETE-15 |
EIA1411 |
overnight at 2-8 C |
1.24 pg/ml |
plasma |
quantitative |
| HETE-15
(S), Correlate EIA |
EIA3630 |
|
|
|
quantitative |
| HEV Ab
Elisa |
EIA4057 |
45'/445' 37C, 15'RT |
neg., pos control qualitative
, >98% |
10 ul serum, plasma (human) |
qualitative |
| HEV Ab Elisa |
EIA4416 |
45/45 min. 37C / 15 min. RT |
pos. / neg. control ** - |
10 uL serum, plasma |
qualitative |
| HEV IgG |
EIA1813 |
75 min. 37 C. |
cutoff value |
serum or plasma |
qualitative |
| HGH (Human
Growth Hormone) |
EIA1787 |
1 hr at RT |
0.5 ng/ml |
serum |
quantitative |
| HIAA
(5-Hydroxy-3-Indole Acetic Acid) |
EIA1886 |
overnight at 2-8 C. |
0.2 mg/L |
urine |
quantitative |
| HIAA ,
5-HIAA (urine) |
EIA4482 |
60/60/20-30 min |
0.5 - 50 mg/l **
0.17 mg/l |
50 ul urine |
quantitative |
| Histamine |
EIA1302 |
120 min. |
0.37-270 ng/ml |
plasma, urine |
quantitative |
| Histamine
Cell Culture Research Elisa |
EIA4616 |
15/30/10/15 min |
0.5 - 50 ng/ml **
0.2 ng/ml |
10 ul cell cultue |
quantitative |
| Histamine
Elisa - |
EIA4005 |
|
|
serum, plasma, urine, cell
culture, liquor |
qualitative |
| Histamine
Food Elisa |
EIA4428 |
30 / 10 / 15 min |
0,5 - 50 ug/l **
0.15 ug/l |
100 uL of extracts of fish meal,
fresh fish, |
quantitative |
| Histamine
Intolerance (DAO active) Elisa |
EIA4599 |
overnight, 30/45/90/30 min 37 C/
15 min RT |
6 to 60 U / ml **
2.5 U/ml. |
250 ul plasma or serum |
quantitative |
| Histamine
Research Elisa |
EIA4890 |
60/30min, Acylation; 15-20h 2-8C/
60/30 min RT |
0.3 - 30 ng/ml **
0.2 ng/mL |
10ul EDTA- plasma from diff.
animal species (+ other sample types) |
quantitative |
| Histone,
anti- Elisa |
EIA3568 |
|
|
|
quantitative |
| HIV
1&2&0&P24 Elisa |
EIA4847 |
60/30/30 min 37C / 30 min RT |
--- **
up to 100 % pos./neg. control |
150 uL serum, plasma |
qualitative |
| HIV 1+2 Elisa |
EIA1423 |
70 min. at RT |
|
serum or plasma |
quantitative |
| HIV 1+2
IgG/M |
EIA3491 |
30/15 min 37 C; 15 min. RT |
pos. / neg. control |
20 ul serum |
qualitative |
| HIV 1+2,
anti- (Sandwich) (ELISA) |
EIA3897 |
|
|
|
qualitative |
| HIV 1+2+0 Ab |
EIA3904 |
45'/45' 37C, 15'RT |
pos./neg. control, qualit. / >99 % |
10 ul serum, plasma (human) |
qualitative |
| Homocysteine |
EIA2925 |
|
|
|
quantitative |
| Homocysteine
Controls |
EIA3329 |
|
|
|
|
| hPL
(Placental Lactogen, Human) |
EIA1283 |
40 min. at RT |
1.25-20 mg/ml |
serum |
quantitative |
| HPV
(High-Risk) PCR Fluorescene Detection Kit |
PCR4785 |
abt. 100 - 110 min |
diff. for ea. of the 13 detectable
HPV t |
Cervical Specimen |
qualitative |
| HPV
Genotyping Kit |
PCR4786 |
220 min. |
diff. for each of the 13 detectable HPV |
Cervical Specimen |
qualitative |
| HPV IgG,
Elisa |
EIA4907 |
60/60 min 37C / 20 min RT |
|
10 uL serum, plasma |
qualitative |
| HsP 70
(anti human Hsp 70) (heat shock protein) Elisa |
EIA4470 |
120 / 60 / 15 min. |
31.25 - 10,000 ng/mL **
6.79 ng/mL |
100 uL serum |
quantitative |
| HSV 1 IgA*,
Elisa |
EIA2532 |
|
|
|
|
| HSV 1 IgG |
EIA1802 |
90 min at RT |
|
serum |
quantitative |
| HSV 1 IgG
(Herpes Simplex Virus) |
EIA3485 |
60 37 C; 30 / 15 min. RT |
pos. / neg. / cut off control |
10 ul serum (1+100 diluted) |
qualitative |
| HSV 1 IgG (Herpes Simplex
Virus) |
EIA2799 |
20, 20, 10 RT |
|
serum: 10uL |
qualitative |
| HSV 1 IgM |
EIA1803 |
90 min at RT |
|
serum |
quantitative |
| HSV 1 IgM
(Herpes Simplex Virus) |
EIA3486 |
60 37 min. C; 30 / 15 min. RT |
pos. / neg. / cut off control |
10 ul serum (1+100 diluted) |
qualitative |
| HSV 1 IgM
(Herpes Simplex Virus) |
EIA2800 |
20, 20, 10 RT |
|
serum: 10uL |
qualitative |
| HSV 1+2 IgG
(Herpes Simplex Virus) |
EIA3489 |
60 min. 37 C; 30 / 15 min. RT |
pos. / neg. control |
10 ul serum (1+1)) diluted) |
|
| HSV 1+2 IgM
(Herpes Simplex Virus) |
EIA3490 |
60 min. 37 C; 30 / 15 min. RT |
pos./ neg. / cut off control |
10 ul serum (1+100 diluted) |
qualitative |
| HSV 1+2 IgM
(Herpes Simplex Virus) |
EIA2803 |
20, 20, 10 RT |
|
serum: 10uL |
qualitative |
| HSV 2 IgG |
EIA1795 |
90 min at RT |
|
serum |
quantitative |
| HSV 2 IgG
(Herpes Simplex Virus) |
EIA3487 |
60 min 37 C; 30 / 15 min. RT |
pos./ neg. / cut off control |
10 ul serum (1+100 diluted) |
qualitative |
| HSV 2 IgG
(Herpes Simplex Virus) |
EIA2801 |
20, 20, 10 RT |
|
serum 10uL |
qualitative |
| HSV 2 IgM |
EIA1794 |
90 min at RT |
|
serum |
quantitative |
| HSV 2 IgM
(Herpes Simplex Virus) |
EIA3488 |
60 min 37 C; 30 / 15 min. RT |
pos. / neg. / cut off control |
10 ul serum (1+100 diluted) |
qualitative |
| HSV 2 IgM
(Herpes Stimplex Virus) |
EIA2802 |
20, 20, 10 RT |
|
serum, 10uL |
qualitative |
| HTLV
1+2 (min order 2 kits) |
EIA1811 |
75 min. at 37 C. |
|
serum or plasma |
qualitative |
| HTLV 1+2 Ab
(Human T-cell Lymphotropic Virus type 1+2) |
EIA3905 |
45'/45' 37C, 15' RT |
pos./neg. control, qualit. / >98 % |
10 ul serum, plasma (human |
qualitative |
| HVA |
EIA1573 |
85 min. at RT |
0.125-10 mg/ml |
urine |
quantitative |
| I |
|
|
|
|
|
| IA-2 Ab |
EIA4088 |
60/60/20/20 min (RT) |
25 -8000 U/mL ** - |
50 ul serum |
quantitative |
| IAA
(Insulin Autoantibody) |
EIA1593 |
16 hrs. at RT |
-/+ controls |
serum |
quantitative |
| IBR
Blocking AB, 3 steps high sensitivity |
EIA3160 |
|
|
|
|
| ICA
(Intra-Cell Autoantibody) |
EIA1594 |
150 min. at RT |
-/+ controls |
serum |
qualitative |
| ICA
2-Screen Elisa (Islet Cell Autoantibody) |
EIA4253 |
overnight (16-20h) 2- 8 C / 60 /
20 min (RT) |
4 - 450 U/mL ** - |
50 ul serum |
quantitative |
| ICAM-1
(Intracellular Adhesion Molecule-1) or CD54 |
EIA1194 |
3 hrs. at RT |
0.3 ng/ml |
serum or plasma |
quantitative |
| I-FABP
Elisa |
EIA4420 |
60 / 60 / 60 / 30 min. |
20 to 5,000 pg/ml **
20 pg/ml |
100 ul serum, plasma, urine, cell
cuture medi |
quantitative |
| IgA
Salivary Elisa |
SLV4636 |
60 / 15 min |
2.5 - 2500 ug/mL **
0.5 ug/mL |
10 uL saliva |
quantitative |
| IgA-CIC
Elisa |
EIA3988 |
120/60/30 min |
controls qualitative |
200 ul serum, plasma |
qualitative |
| IgE
(Immunoglobulin E) |
EIA1788 |
80 min. at RT |
|
serum |
quantitative |
| IGF 1
(equine) Elisa |
EIA3982 |
90/30 min |
0 - 1440 ng/ml /
8ng/ml |
50 ul heparin plasma or serum |
quantitative |
| IGF BP-1
(PP12) Elisa |
EIA3780 |
60'/15' |
0 - 50 ng/ml |
50 ul |
quantitative |
| IGF BP-3
Elisa |
EIA3300 |
90/30 min |
360 - 6900 ng/ml **
10.5 ng/ml |
10 ul serum |
quantitative |
| IGF-1 -
600 quantitative Elisa |
EIA4140 |
120/60/30 min |
0 - 600 ng/mL / - |
50 ul serum |
quantitative |
| IgG-CIC
Elisa |
EIA3986 |
120/60/30 min |
controls qualitative |
20 ul serum, plasma |
qualitative |
| IgM-CIC
Elisa |
EIA3987 |
120/60/30 min |
controls qualitative |
200 ul serum, plasma |
qualitative |
| Influenza A
IgA Elisa |
EIA4242 |
60
37C; 30 / 15 min. RT |
pos. / neg. control |
10 ul serum (1+100 diluted) |
qualitative |
| Influenza A
IgG Elisa |
EIA4238 |
60
37C, 30 / 15 min. RT |
pos. / neg control |
10 ul serum (1+100 diluted) |
qualitative |
| Influenza A
IgM Elisa |
EIA4240 |
60 37C; 30 / 15 min. RT |
pos. / neg. / cut off control |
10 ul serum (1+100 diluted) |
qualitative |
| Influenza B
IgA Elisa |
EIA4239 |
60
37 C; 30 / 15 min. RT |
pos./ neg. / cut off control |
10 ul serum (1+100 diluted) |
qualitative |
| Influenza B
IgG Elisa |
EIA4241 |
60
37 C; 30 / 15 min. RT |
pos. / neg. control |
10 ul serum (1+100 diluted) |
qualitative |
| Influenza B
IgM Elisa |
EIA4237 |
60 37C; 30/15 min RT |
pos. / neg. control |
10 ul serum (1+100 diluted) |
qualitative |
| Insulin
(Bovine) Elisa |
EIA4748 |
120 / 15 min |
0.05 - 3 ug/L **
0.025 ug/L |
25 uL serum / plasma |
quantitative |
| Insulin
(Canine) Elisa |
EIA4749 |
120 / 15 min |
0.02 - 1.5 ug/L **
0.01 ug/L |
25 uL serum / plasma |
quantitative |
| Insulin
(Equine) Elisa |
EIA4746 |
120 / 15 min |
0.02 - 1.5 ug/L **
0.01 ug/L |
25 uL serum / plasma |
quantitative |
| Insulin
(Feline) Elisa |
EIA4919 |
120 / 30 min |
5 - 700 ng/l **
0.01 ug/L |
10 ul serum/ plasma |
quantitative |
| Insulin
(human) |
EIA1825 |
1 hour @ RT |
1.5 ulU/ml |
serum / plasma |
quantitative |
| Insulin
(human) |
EIA2935 |
1 hr RT |
1.5 iU/ml |
serum, plasma |
quantitative |
| Insulin
(mouse) EIA |
EIA3439 |
|
|
|
|
| Insulin
(mouse) ultrasensitive EIA |
EIA3440 |
120 / 30 min |
5ul sample: 0.22 - 7.1 ug/l, 50ul
sample: 0.025 |
5 ul or 50 ul mouse serum, plasma
or fluid |
|
| Insulin
(ovine) Elisa |
EIA4739 |
120 / 15 min |
0.05 - 3 ug/L **
0.025 ug/L |
25 uL serum / plasma |
quantitative |
| Insulin
(Porcine) Elisa |
EIA4747 |
120 / 15 min |
0.02 - 1.5 ug/L **
0.01 ug/L |
25 uL serum / plasma |
quantitative |
| Insulin
(rat) |
EIA2048 |
60/15 min. |
0.15-5.5 ug/L |
25 ul serum, plasma |
quantitative |
| Insulin
(rat) ultrasensitive, ELISA |
EIA2943 |
|
|
|
|
| Insulin
(rat/mouse) |
EIA4127 |
120/30/15 min. |
0.2 - 10 ng/ml ** 0.2 ng/ml'2 ng - 10 ng per ml |
20 ul serum, plasma |
quantitative |
| Insulin
anti- Elisa |
EIA3608 |
|
|
|
quantitative |
| Insulin Iso
ELISA |
EIA2336 |
60/15 min. |
3-100 mU/L |
|
|
| Insulin rat
high range ELISA |
EIA3985 |
120/15 min |
3 - 150 ug/l /
1.5ug/l |
10 ul serum, plasma |
quantitative |
| Insulin
Ultra-Sensitive |
EIA2337 |
60/15/min. |
0.15 - 10 mU/L |
50 ul serum, plasma |
|
| Inferferon
gamma (porcine) Elisa |
EIA4828 |
1hr/ 1hr/ 30 min/10 min. at RT |
31-2000 pg/mL **
3.3 pg/mL |
50 ul cell culture, serum, plasma
other biol. Fluids |
quantitative |
| Interferon
alpha (human) Elisa |
EIA4766 |
120 / 15 min |
8-500 pg/ml **
3.16 pg/ml |
20 ul cell culture supernatants,
human serum, |
quantitative |
| Interferon
beta |
EIA2088 |
|
|
|
|
| Interferon
gamma (rat) - INF - |
EIA4582 |
120 / 60 / 45 min 37C / 20 min RT |
21.8 - 1400 pg/mL
** <13 pg/mL |
100 ul serum, plasma, buffered
solution, or cell culture medium |
quantitative |
| Interferon
gamma (rat) - INF - |
EIA4583 |
120 / 60 / 45 min 37C / 20
min RT |
21.8 - 1400 pg/mL **
<13 pg/mL |
100 ul serum, plasma, buffered
solution, or cell culture medium |
quantitative |
| Interferon
gamma Elisa / CE |
EIA4434 |
120 / 15 min |
1 - 30 IU/ml **
0.03 IU/ml |
50 uL serum |
quantitative |
| Interferon
y (human) EIA |
EIA3277 |
120/15 min. at 24 C |
1 - 30 IU / ml |
50 ul human serum |
quantitative |
| Interferon
y (human) EIA |
EIA3278 |
120/15 min. at 24 C |
1-30 IU/ml |
50 ul human serum |
quantitative |
| Interferon
y (mouse) EIA |
EIA3378 |
3h/30min |
7.8 - 500 pg/ml |
100 ul serum and tissue culture
supernatant |
quantitative |
| Interferon
y (mouse) Elisa |
EIA3299 |
3h/30min |
7.8 - 500 pg/ml |
100 ul Serum, tissue culture
supernatant |
quantitative |
| Interferon
y (porcine) EIA |
EIA3178 |
incubation time: 3 hours |
7.8 500 pg/ml |
50 ul serum, plasma, cell culture
medium + 50 |
quantitative |
| Interferon
/ Anti-IFN alpha (human) Elisa |
EIA4853 |
2 hrs / 1 hr / 10 min |
3.2 - 200 ng/mL **
1.38 ng/mL |
20 ul cell culture, serum, plasma,
urine |
quantitative |
| Interleukin
1 (alpha) (rat) EIA |
EIA3281 |
4 hours |
7.8 - 500 pg/ml |
50 ul rat serum |
quantitative |
| Interleukin
1 (beta) (human) |
EIA0977 |
4 hrs |
10.24-400 pg/mL ** <1 pg/mL |
50 ul |
quantitative |
| Interleukin
1 (beta) (mouse) |
EIA1604 |
3 hrs |
15.6-1,000 pg/mL ** <3 pg/mL |
50 uL |
quantitative |
| Interleukin
1 (beta) (mouse) |
EIA3379 |
2h/30 min |
15, 16 - 1000 pg/ml |
50 ul serum, tissue culture
supernatant |
quantitative |
| Interleukin
1 (beta) (mouse) Elisa |
EIA3302 |
2h/30 min |
15.16 - 1000 pg/ml |
50 ul Serum, tissue culture
supernatant |
quantitative |
| Interleukin
1 (beta) (porcine) EIA |
EIA3180 |
Incubation time: 4 hours |
39 - 2500 pg / ml |
50 ul serum, plasma, cel culture
medium + 50 |
quantitative |
| Interleukin
1 (beta) (porcine) EIA |
EIA3181 |
Incubation time: 4 hours |
39 - 2500 pg/ml |
50 ul serum, plasma, cell culture
medium + 50 |
quantitative |
| Interleukin
1 (beta) (rat) |
EIA3541 |
3 hrs 30 min |
25.6-2,500 pg/mL ** < 12 pg/mL |
50 uL |
quantitative |
| Interleukin
1 (beta) Elisa / CE |
EIA4437 |
120 / 15 min |
24 - 1166 pg/ml **
2 pg/ml |
200 uL serum |
quantitative |
| Interleukin
1 Receptor Antagonist (IL-1ra) Elisa |
EIA4500 |
2h / 1h/ 30 min. |
31.2-2000 pg/ml **
4pg/ml |
100 ul serum, plasma, cell
culture, other bio |
quantitative |
| Interleukin
10 |
EIA1609 |
165 min. at RT |
10-500 pg/ml |
serum, plasma |
quantitative |
| Interleukin
10 |
EIA4699 |
4 h 30 min at RT |
11-1335 pg/ml **
1 pg/ml |
100 uL serum |
quantitative |
| Interleukin
10 (mouse) |
EIA3380 |
4 h |
31.2-2,000 pg/ml |
100 ul serum, plasma, cell culture
supernatant |
quantitative |
| Interleukin
10 (mouse) Elisa |
EIA3298 |
4 h |
31.2-2,000 pg/ml |
100 ul Serum, Plasma, cell culture
supernatant |
quantitative |
| Interleukin
10 (porcine) EIA |
EIA3184 |
Incubation time: 3 hours |
7.8 - 500 ul/ml |
50 ul serum, plasma + 50 ul
diluent, 100 ul Cell culture supernatant |
quantitative |
| Interleukin
10 (porcine) EIA |
EIA3185 |
Incubation time: 3 hours |
7.8 - 500 pg/ml |
50 ul serum, plasma + 50 ul
diluent, 100 ul Cell culture supernatant |
quantitative |
| Interleukin
10 (rat) Elisa |
EIA3166 |
3.5 hrs. in total |
0-2000 pg/ml |
100ul Serum, Plasma |
quantitative |
| Interleukin
10 (rat) Elisa |
EIA4773 |
120 / 60/ 15 min |
15.6 - 1000 pg/ml ** 1.47 pg/ml |
50 ul cell culture supernatants,
human serum, |
quantitative |
| Interleukin
12 +p40 Elisa |
EIA4698 |
4 h 30 min. at RT |
15 - 1300 pg/ml **
1.5 pg/ml |
100 ul serum |
quantitative |
| Interleukin
12 p70 (rat) Elisa |
EIA4001 |
120/60/30/30 min |
7.8 - 500 pg/ml / <2.5 pg/ml |
100 ul cell extract |
quantitative |
| Interleukin
13 (human) Elisa |
EIA3410 |
|
|
|
|
| Interleukin
13 (rat) |
EIA3391 |
120 / 30 / 30 min |
7.8 - 500 pg/mL ** 1.5 pg/mL |
25 uL serum, plasma / 50 uL
buffered solution |
quantitative |
| Interleukin
13 (rat) Elisa |
EIA3411 |
|
|
|
quantitative |
| Interleukin
15 (human) |
EIA3392 |
|
|
|
quantitative |
| Interleukin
15 (human) Elisa |
EIA3412 |
|
|
|
quantitative |
| Interleukin
16 (human) |
EIA3393 |
|
|
|
quantitative |
| Interleukin
16 (human) Elisa |
EIA3413 |
|
|
|
|
| Interleukin
18 (human) |
EIA4061 |
60/60/30 min. at RT |
15.6 - 1000 pg/mL , 12.5 pg/mL |
100 uL serum, plasma, cell culture
supernatant |
quantitative |
| Interleukin
18 (rat) |
EIA4002 |
120/60/30/30 min at RT |
15.6 - 1000 pg/ml /
< 4pg/ml |
100 ul serum, plasma, cell culture
med., buff. sol. |
quantitative |
| Interleukin
18 (rat) |
EIA4059 |
120/60/30/30 min at RT |
15,6 - 1000pg/mL < 4 pg/mL |
100 ul serum, plasma, cell culture
med., buff. sol. |
quantitative |
| Interleukin
2 |
EIA0064 |
4 hrs at 37 C. |
0.17 units/ml |
|
quantitative |
| Interleukin
2 (mouse) |
EIA1605 |
235 min. at RT |
50-2000 pg/ml |
serum |
quantitative |
| Interleukin
2 (mouse) |
EIA3163 |
3.5 hrs. in total |
15 1000 pg/ml |
50ul Serum, Plasma |
quantitative |
| Interleukin
2 (mouse) Elisa |
EIA3155 |
3.5 hrs. in total |
15 - 1000 pg/ml |
50ul Serum, Plasma |
quantitative |
| Interleukin
2 (porcine) |
EIA3382 |
|
|
|
|
| Interleukin
2 (rat) |
EIA3381 |
|
|
|
quantitative |
| Interleukin
2 (rat) |
EIA3407 |
120 / 30 / 30 min |
23.4 - 1500 pg/mL **
<5pg/mL |
50 uL serum, buffered solution, or
cell cultu |
quantitative |
| Interleukin
2 Elisa / CE |
EIA4436 |
120 / 15 min. |
0.78 - 23.8 U/ml **
0.05 U/ml |
100 uL serum |
quantitative |
| Interleukin
3 (human) Elisa |
EIA3289 |
|
|
10 ul Serum, plasma, cell culture
supernatant |
quantitative |
| Interleukin
3 (human) Elisa |
EIA3408 |
|
|
|
quantitative |
| Interleukin
3 (mouse) |
EIA3383 |
90 / 45 / 30 min |
7.8 - 500 pg/mL /
<3 pg/mL |
50 ul serum, buffered solution, or
cell culture medium |
quantitative |
| Interleukin
4 (mouse) |
EIA1607 |
165 min. at RT |
10-500 pg/ml |
serum, plasma |
quantitative |
| Interleukin
4 (mouse) |
EIA3384 |
3 h / 15 min. |
15.6 - 1000 pg/ml |
50 ul serum tissue culture
supernatant |
quantitative |
| Interleukin
4 (mouse) Elisa |
EIA3291 |
3 h / 15 min |
15.6 - 1000 pg/ml |
50 ul Serum tissue culture
supernatant |
quantitative |
| Interleukin
4 (porcine) |
EIA4091 |
120/30/30 min. at RT |
0 - 1000 pg/mL ** 2 pg/mL |
50 ul serum, plasma, cell culture
med., buffered solution |
quantitative |
| Interleukin
4 (rat) |
EIA3385 |
|
|
|
|
| Interleukin
4 Elisa / CE |
EIA4435 |
120 / 30 min |
14.5 - 1696 pg/ml **
1.2 pg/ml |
100 uL serum |
quantitative |
| Interleukin
5 (mouse) |
EIA3396 |
120 / 60 / 30 / 30 min. |
7.8 - 500 pg/mL /
<3pg/mL |
50 uL serum, plasma / 100 uL
buffered solutio |
quantitative |
| Interleukin
5 (mouse) |
EIA3401 |
|
|
|
|
| Interleukin
6 (human) |
EIA1200 |
150 min. at 37 C. |
7 pg/mL |
serum or plasma |
quantitative |
| Interleukin
6 (mouse) |
EIA1608 |
165 min. at RT |
25-1000 pg/ml |
serum |
quantitative |
| Interleukin
6 (mouse) |
EIA3386 |
|
|
|
|
| Interleukin
6 (mouse) Elisa |
EIA3403 |
120 / 30 / 30 / 30 min |
7.8 - 500 pg/mL **
<3 pg/mL |
50 ul serum, plasma / 100 uL
buffered solution |
quantitative |
| Interleukin
6 (rat) Elisa |
EIA3294 |
4 h |
31.2 - 2,000 pg/ml |
50 ul Serum, tissue culture
supernatant |
quantitative |
| Interleukin
6 Elisa / CE |
EIA4640 |
60 / 60/ 15 min |
23,3 - 2560 pg/ml **
2 pg/ml |
100 ul serum |
quantitative |
| Interleukin
6 Titerzyme (human) |
EIA0979 |
120 min. at 37 C. |
4.1 pg/ml |
serum, cell culture |
quantitative |
| Interleukin
6R hs (human soluble) |
EIA4423 |
120 / 30 / 30 min |
62,5 - 4000 pg/ml **
<8 pg/ml |
20 ul serum / plasma |
quantitative |
| Interleukin
7 (human) Elisa |
EIA3295 |
4h / 40 min. |
15.6 - 1,000 pg/ml |
100 ul serum, tissue culture
supernatant |
quantitative |
| Interleukin
8 (porcine) EIA |
EIA3182 |
Incubation time: 4 hours |
31.2 - 2000 pg / ml |
50 ul Serum, plasma + 50 ul
diluent, 100 ul cell culture supernatant |
quantitative |
| Interleukin
8 (porcine) EIA |
EIA3183 |
Incubation time: 4 hours |
31.2 - 2000 pg/ml |
50 ul Serum, plasma + 50 ul
diluent, 100 ul cell culture supernatant |
quantitative |
| Interleukin
8 Elisa |
EIA4700 |
2 h 30 min at RT |
7-750 pg/ml **
0.7 pg/ml |
100 uL serum |
quantitative |
| Interleukin-1
beta (rat) Elisa |
EIA4911 |
2hrs / 1 hr/ 10 min. at RT |
31.25-2000 pg/mL **
4.4 pg/mL |
50 ul cell culture, serum, plasma
other biol. fluids |
quantitative |
| Interleukin-12
(mouse) Elisa |
EIA4920 |
120/60/10 min |
31.25 - 2000 pg/mL **
3.96 pg/mL |
50 ul cell culture, serum, plasma
other biol. fluids |
quantitative |
| Interleukin-12p70
(human) Elisa |
EIA4843 |
2 hrs / 1 hr / 10 min. at RT |
3.2 - 200 pg/mL **
2.11 pg/mL |
50 ul cell culture, serum, plasma
other biol. fluids |
quantitative |
| Interleukin-12p70
(mouse) Elisa |
EIA4842 |
2hrs / 1 hr/ 10 min at RT |
15.6 - 1000 pg/mL **
<10.0 pg/mL |
50 ul cell culture, serum, plasma
other biol. fluids |
quantitative |
| Interleukin-13
(human) Elisa |
EIA4841 |
1 nr/ 10 min |
1.56 - 100 pg/mL **
0.73 pg/mL |
50 ul cell culture, serum, plasma
other biol. fluids |
quantitative |
| Interleukin-17
A (human) Elisa |
EIA4840 |
2 hrs / 1 h/ 10 min |
1.6 - 100 pg/mL **
0.5 pg/mL |
50 uL cell culture, serum, plasma
(citrate and heparinized) |
quantitative |
| Interleukin-2
Receptor (human) Elisa |
EIA4835 |
3 hrs / 10 min |
0.31-20 ng/mL **
0.27 ng/mL |
50 ul cell culture, serum, plasma
other biol. fluids |
quantitative |
| Interleukin-5
(human) Elisa |
EIA4832 |
2 hrs/ 1 hr/ 10 min. at RT |
7.8 - 500 pg/mL **
1.45 pg/mL |
50 ul cell culture, serum, plasma
other biol. fluids |
quantitative |
| Interleukin-6
Receptor (human) Elisa |
EIA4844 |
3 hrs / 10 min |
8-500 ng/mL **
0.01 ng/mL |
50 ul cell culture, serum, plasma,
amniotic fluids. other biol. fluids |
quantitative |
| Interleukin-1
alpha (human) Elisa |
EIA4839 |
2 hrs/ 1 hr / 10 min. at RT |
1.6 - 100 pg/mL
** 1.06 pg/mL |
50 ul cell culture, serum, plasma
(EDTA + citrate) urine |
quantitative |
| Interleukin-6
(rat) Elisa |
EIA4845 |
2 hrs / 1 hr / 10 min. at RT |
31.3 - 2000 pg/mL **
12 pg/mL |
50 ul cell culture, serum, plasma
other biol. fluids |
quantitative |
| Involucrin
(human) (Tissue Cell Staining Kit) |
EIA0141 |
100 min. |
|
serum |
qualitative |
| Involucrin
Elisa |
EIA0144 |
Overnight at 4C |
0.05-0.5 ng/well |
serum |
quantitative |
| J |
|
|
|
|
|
| Japanese
Encephalitis IgG (JE) Elisa |
EIA4518 |
60/60 min. 37 C; 5/10/1 min RT |
- **
99 % |
4 ul serum (dilution 1:300) |
qualitative |
| Jo-1 IgG |
EIA2787 |
10, 20, 10 RT |
|
serum, 10uL |
semi-quant. |
| Jo-1,
anti- Elisa |
EIA3581 |
|
|
|
quantitative |
| L |
|
|
|
|
|
| Lactalbumin
- alpha-Lactalbumin IgA |
EIA4301 |
30 / 30 / 10 min |
pos. and neg. control |
10 ul serum, plasma (1:100
diluted) |
qualitative |
| Lactalbumin
= alpha-Lactalbumin IgG |
EIA4293 |
30 / 30 / 10 min |
pos. and neg. control |
10 ul serum, plasma (1:100
diluted) |
qualitative |
| Lactate
Salivary Test |
SLV4764 |
30/10 min |
0.25 - 4 mmol/L **
0.08 mmol/L |
25 ul Saliva |
quantitative |
| Lactoferrin,
anti- Elisa |
EIA3602 |
|
|
|
quantitative |
| Lactoglobulin
= beta-Lactoglobulin IgG |
EIA4302 |
30 / 30 / 10 min |
pos. and neg. control |
10 ul serum, plasma (1:100
diluted) |
qualitative |
| Lactoglobulin
= beta-Lactoglobulin IgG Elisa |
EIA4294 |
30 / 30 / 10 min. |
pos. and neg. control |
10 ul serum, plasma (1:100
diluted) |
qualitative |
| LC -
Anti-LC-1 Elisa |
EIA4276 |
30/15/15/ min at RT |
0-300U/ ml ** 1.0 U/ml |
10 ul serum, plasma (1:101
diluted) |
quantitative |
| LDL ox EIA
(oxidased low density lipoporteins) (sandwich) |
EIA3430 |
|
|
|
quantitative |
| LDL ox
Elisa (competitive) |
EIA4261 |
120 / 60 / 15 min |
0.5 - 9.7 U/l / < 0.3 U/l |
50 ul serum (1:41 diluted) |
quantitative |
| Legionella
IgG/IgM/IgA |
EIA2814 |
20, 20, 10 RT |
|
serum: 10uL |
qualitative |
| Legionella
pneumophila Ag (urine) |
EIA4205 |
10 / 5 / 5 min. |
pos. / neg. control **
- |
100 ul urine |
qualitative |
| Leishmania
Ab Canine Elisa |
EIA4796 |
? |
neg. / pos. control |
? |
qualitative |
| Leishmania
donovani IgG (canine) Elisa |
EIA4690 |
30 / 15 / 10 min |
pos. and neg. control |
5 ul serum |
qualitative |
| Leishmania
IgG |
EIA3492 |
10 / 10 / 5 min. |
pos. / neg. control **
- |
100 ul serum (diluted 1:40) |
qualitative |
| Leptin
(human) (Sandwich EIA) |
EIA2395 |
120/30/30/15 min |
2 - 100 ng/ml **
1.0 ng/ml |
15 ul serum, plasma |
quantitative |
| Leptin
(mouse) Elisa |
EIA4564 |
2 h / 1 h / 30 min. |
0.2, 0.5, 1, 2, 5, 10, 20, 30
ng/ml ** 0.05 ng/ |
25 or 50ul serum, plasma and other
biological media |
quantitative |
| Leptin
(mouse/rat) Elisa |
EIA4551 |
60/60/30/10 min. |
100 - 4000 pg / ml / 0.15 ng/ml |
7 ul serum, plasma and tissue
culture medium |
quantitative |
| Leptin
(rat) |
EIA3115 |
60 / 30 min 37 C / c0 min RT |
56 - 3600 pg/ml **
46.7 pg/mL |
100 uL biological fluids |
quantitative |
| Leptin
(rat) Elisa |
EIA4607 |
120/60/30/15 min |
0.2 - 30 ng/ml **
0.04 ng/ml |
10 ul serum, plasma and other
biological medium |
quantitative |
| Leptin
Receptor Elisa human |
EIA3527 |
60 / 60 / 10 min |
2 - 100 ng/ml **
1.2 ng/ml |
50 ul serum, plasma/ tissure
culture (diluted 1:3) |
quantitative |
| Leptospira
Hardjo antibodies, MCA based, cattle |
EIA2498 |
|
Positive and Negative Control |
|
|
| Leptospira
IgG Elisa |
EIA4245 |
10/10/5 min |
pos./ neg. control |
10 ul serum (diluted 1:40) |
qualitative |
| Leptospira
IgG+IgM Elisa |
EIA4727 |
10 / 10 / 5 min. |
pos./neg. control **
- |
10 ul serum/plasma (diluted 1:40) |
qualitative |
| Leptospira
IgM Elisa |
EIA4715 |
10/10/5 min |
pos. / neg. control **
- |
10 ul serum (diluted 1:40) |
qualitative |
| Leukotriene
B4 Elisa (LTB4) Parameter Assay Kit |
EIA3088 |
|
7.8 - 2,000 pg/ml |
10 ul plasma, urine or tissue
homogate ( diluted w. Assay Buffer or extracted) |
quantitative |
| Leukotriene
C4/D4/E4, Elisa |
EIA2926 |
|
|
|
qualitative |
| LH
(Lutenizing Hormone) serum |
EIA1289 |
40 min. at RT |
10-200 mIU/ml |
serum |
quantitative |
| LH
(Lutenizing Hormone) urine |
EIA1290 |
40 min. at RT |
10-200 mIU/ml |
urine |
quantitative |
| LH
(Lutenizing Hormone-Releasing Hormone) (H - R - M - P) |
EIA1174 |
4 hrs. at RT |
0.02-0.05 ng/mL |
serum |
quantitative |
| LIF-HILDA |
EIA3878 |
4h / 30 min |
300 - 3500 pg/mL 20pg/mL |
100 ul |
quantitative |
| Lipase
(pancreatic h-p-Lipase) Elisa |
EIA4459 |
30 / 15 min |
10 - 400 U/L / 5
U/L |
25 uL serum |
quantitative |
| Lipoprotein
(a) Lp (a) |
EIA4406 |
60/60/30 min. |
1 - 165 mg/dL **
/ |
100 ul serum, plasma (diluted
1:500) |
quantitative |
| LKM -
Anti-LKM-1 Elisa |
EIA4277 |
30/15/15 min at RT |
0-300U/ ml ** 1.0 U/ml |
10 ul serum, plasma (1:101)
diluted) |
quantitative |
| Lypocheck
Immunoassay tri-level control |
EIA2979 |
|
|
|
|
| Lysozyme
(human) Sandwich Elisa |
EIA3035 |
|
|
|
quantitative |
| Lysozyme
anti- Elisa |
EIA3601 |
|
|
|
quantitative |
| M |
|
|
|
|
|
| Malaria
Elisa |
EIA4263 |
30 / 30 min 37 C; 30 min RT |
neg. / pos. control,
qualitative ** 92.5 - 100 % |
50 ul serum, plasma |
qualitative |
| Marijuana (Cannabinoids) (THC) |
EIA1519 |
45 min. at RT |
|
urine |
quantitative |
| MCP-1
(human) Elisa |
EIA4857 |
2 hrs / 10 m in. at RT |
16 - 1000 pg/mL **
2.31 pg/mL |
100 ul cell culture, serum,
plasma, amniotic |
quantitative |
| MCP-1 (rat)
Titerzyme (Monocyte Chemoattractant Protein 1) |
EIA3620 |
|
|
|
quantitative |
| MCP-1
(rat), (Monocyte Chemoattractant Protein 1) |
EIA4072 |
90 / 30 / 30 min |
11.7-650 pg/mL, < 0.8 pg/mL |
50 ul serum/ plasma/ bufferd
solution / cell |
qualitative |
| Measles IgG |
EIA3495 |
60 min. 37 C; 30 / 15 min. RT |
pos. / neg. control |
10 ul serum (1+100 diluted) |
qualitative |
| Measles IgM |
EIA3496 |
60 min. 37 C; 30 / 15 min RT |
pos. / neg. control |
10 ul serum (1+100 diluted) |
qualitative |
| Melatonin |
EIA1431 |
overnight at 2-8 C |
2.6 pg/ml |
serum or plasma |
quantitative |
| Melatonin
(direct) Saliva Elisa |
SLV4779 |
16-20 hrs 2-8 C, 2 / 1 h/ 15 min.
Rt |
0.5 - 50 pg/mL **
0.3 pg/mL |
100 ul Saliva |
quantitative |
| Melatonin
Sulfate |
EIA1432 |
150 min. at RT |
1 ng/ml |
urine |
quantitative |
| Meningitis
IgG Elis |
EIA4918 |
60/60 min. 37 C / 20 min RT |
pos./neg control **
--- |
10 ul serum/plasma |
qualitative |
| Met Combi
Plasma Elisa |
EIA4865 |
16-20h 2-8C, 90/15-30 min RT |
Metan 40-5275 pg/mL, Normetan:
33-5906 |
300 ul plasma |
quantitative |
| Metanephrine |
EIA2748 |
90/15/60/30/40 min. |
26-2500 ug/L **
8.6 ug/L |
10 ul urine |
quantitative |
| Metanephrine
Plasma Elisa |
EIA4313 |
overnight |
15-3,000pg/ml **
7.5pg/ml |
plasma |
quantitative |
| Metanephrine
urine Elisa |
EIA4315 |
2 hours |
15 - 1,500ng/ml ** 7.5ng/ml |
urine |
quantitative |
| MetCombi
(plasma) (Methanephrine/Normetanephrine) Elisa |
EIA4082 |
15-20h/30/20-30 min |
norm: 0-10000 pg/ml, meth: 0-6000
pg/ml |
500 ul plasma |
quantitative |
| MetCombi
Elisa (Methanephrine/Normetanphrine) |
EIA4083 |
30/30/15-20 min |
norm: 0-6000ng/ml, meth:
0-2000ng/ml |
10 ul urine |
quantitative |
| Methamphetamine |
EIA1510 |
45 min. at RT |
|
serum, plasma, blood |
quantitative |
| Methylphenidate |
EIA1511 |
45 min. at RT |
|
serum, plasma, blood |
quantitative |
| Microalbumin |
EIA2361 |
|
|
|
quantitative |
| Microalbumin Elisa |
EIA3881 |
30'/15' RT |
0.15 - 400 ug/ml 0.5 ug/ml |
20 ul urine |
quantitative |
| Microglobulin,
(anti-beta2) Elisa |
EIA3609 |
|
|
|
quantitative |
| Microglobulin,
(beta-2) |
EIA1789 |
1 hr. at 37 C. |
0.2 ug/ml |
serum |
quantitative |
| Milk
stabilisation kit incl. sterile test tubes (bovine) |
EIA3162 |
|
|
|
|
| MIP-1 beta
(human) (Macrophage Inflammatory Protein-1b) |
EIA3788 |
4h |
15.6-1000 pg/ml 2pg/ml |
50 ul |
quantitative |
| MIP-2 (rat)
(Macrophage Inflammatory Protein-2) |
EIA3789 |
3h / 30' |
10-640 pg/ml <1pg/ml |
50 ul |
quantitative |
| MIP-5
(human) (Macrophage Inflammatory Proterin-5) |
EIA3790 |
3h |
7.8-500 pg/ml < 1 pg/ml |
10 ul (1:20) |
quantitative |
| MMP-13
(human) Elisa |
EIA4862 |
2 hrs / 1 hr/ 20 min. at RT |
0.31 - 20 ng/mL ** 0.18 ng/mL |
50 ul dil. cell culture
supernatant, serum an |
quantitative |
| MMP-3
(Matrix metalloproteinase 3) Elisa |
EIA4620 |
90 / 30 min |
12.5 - 800 ng/ml **
0.075 ng/ml |
40 uL serum |
quantitative |
| MMP-9
(human) Elisa |
EIA4861 |
1 hr / 10 min. at RT |
0.23 - 15 ng/mL **
0.05 ng/mL |
10 ul dil. cell culture
supernatant, serum an |
quantitative |
| Morphien
(urine) Elisa |
EIA4926 |
30 / 30 min |
5-100 ng/ml **
- |
10 ul urine |
quantitative |
| Morphin
(serum/blood) Elisa |
EIA4923 |
30 / 15 min |
1 - 100 ng/ml **
- |
10 ul serum, whole blood |
quantitative |
| Morphine
(serum/blood) Elisa |
EIA4924 |
30/15 min |
1-100 ng/ml **
- |
10 ul serum, whole blood |
quantitative |
| Morphine
(urine) Elisa |
EIA4925 |
30 / 30 min |
5-100 ng/ml **
/ |
10 ul urine |
quantitative |
| MPO
(Myeloperoxidase human) |
EIA4165 |
60/60/30/30 min RT |
0.0 - 12.5 ng/ml ** 0.13 ng/ml |
100 ul biolog. fluids |
quantitative |
| MPO
(Myeloperoxidase) Elisa |
EIA4571 |
60 / 60 / 15 min |
3 - 300 ug/l **
< 3 ug/l |
25 ul serum / plasma |
quantitative |
| MPO
(Myeloperoxidase) IgG (pANCA) |
EIA2776 |
20, 20, 10, RT |
|
serum, 10uL |
semi-quant. |
| MPO (pANCA)
anti- Elisa |
EIA3597 |
|
|
|
quantitative |
| MSH (alpha)
(Melanocyte Stimulating Hormone) (human - rat - mouse) |
EIA2951 |
|
|
|
quantitative |
| Mumps IgG |
EIA3497 |
60 min. 37 C; 30 / 15 min. RT |
pos. / neg. / cut off control |
10 ul serum (1+100 diluted) |
qualitative |
| Mumps IgM |
EIA3498 |
60 min. 37 C; 30 / 15 min. RT |
pos. / neg. control |
10 ul serum (1+100 diluted) |
qualitative |
| Mycoplasma
hominis IgG Elisa |
EIA4559 |
60 / 30 / 15 min. at RT |
pos./neg. / cut-off control |
10 ul serum, plasma |
qualitative |
| Mycoplasma
IgG |
EIA2812 |
20, 20, 10 RT |
|
serum: 10ul |
qualitative |
| Mycoplasma IgM |
EIA2813 |
20, 20, 10 RT |
|
serum: 10uL |
qualitative |
| Mycoplasma
pneumoniae IgG |
EIA3499 |
60 min. 37 C; 30 / 15 min. RT |
pos./ neg. / cut off control |
10 ul serum (1+100 diluted) |
qualitative |
| Mycoplasma
pneumoniae IgM |
EIA3500 |
60 min. 37 C; 30 / 15 min. RT |
pos./ neg. / cut off control |
10 ul serum (1+100 diluted) |
qualitative |
| Myoglobin |
EIA3955 |
|
12 to 90ng/ml **
5ng/ml |
serum and plasma |
quantitative |
| N |
|
|
|
|
|
| Neopterin |
EIA2949 |
|
|
|
|
| Neopterin
Elisa |
EIA1476 |
|
|
|
quantitative |
| Neopterin
Elisa |
EIA4366 |
60 / 30 min. |
1.35 - 111 nmol/L **
0.32 nmol/L |
10 ul serum |
quantitative |
| NGAL
(human) Elisa ( <neutrophil gelatinase-associated lipocalin) |
EIA4893 |
60/60/60/10 min |
10 - 1000 pg/ml **
4 pg/ml |
10 ul tissue fluids (e.g. plasma,
srum or uri |
|
| Nitric
Oxide (total) Assay kit |
EIA3639 |
|
|
|
|
| Nitric
Oxide Assay Kit (Colorimetric Nitric Oxide) |
EIA3638 |
|
|
|
|
| Noradrenalin
(Norepinephrine) |
EIA2049 |
14-20 h 120/120/20 min. |
5-500 ng/ml |
20 ul urine (extraction) |
quantitative |
| Noradrenalin
Research Elisa |
EIA4706 |
Acylation: 55 min. EIA: 30/120/30
min |
8 - 2048 pg/sample ** 2.7 pg/sample |
1-100 uL tissue extracts,
dialysates, small amounts of urine + plasma |
quantitative |
| Noradrenaline
Elisa |
EIA4317 |
3,5 hours |
4-1,024mg/ml ** urine: 2ng/ml ,
plasma: 67pg/ml |
plasma, urine |
quantitative |
| Normetanephrine
plasma Elisa |
EIA4319 |
overnight |
30 - 6,000 pg/ml ** 15pg/ml |
plasma |
quantitative |
| Normetanephrine
urine Elisa |
EIA4321 |
2 hours |
40-4,000ng/ml ** 20ng/ml |
urine |
quantitative |
| Normethanephrine |
EIA2749 |
90/15/60/30/20 min |
77-7500 ug/L **
12 ug/L |
10 ul Urine |
quantitative |
| Norovirus
(stool) Elisa |
EIA4864 |
60 / 30 / 15 min |
neg. and pos. control **
93.3 |
100 ul or 50 -100 mg stool |
qualitative |
| NSE |
EIA4424 |
60 / 30 min |
5 - 200 ug/L **
1ug/L |
25 uL serum |
quantitative |
| NSE (Neuron
specific Enolase) |
EIA2353 |
|
|
|
quantitative |
| NSE Elisa |
EIA4610 |
60 / 15 min |
4 - 100 ng/mL **
4 ng/mL. |
25 uL serum |
quantitative |
| NT-proBNP
direct Elisa |
EIA4827 |
3h / 30 min |
10-640 fmol/ml **
3 fmol/ml |
50 ul serum, plasma |
quantitative |
| O |
|
|
|
|
|
| Opiates
(serum/blood) Elisa |
EIA4927 |
30 / 30 min |
5 - 500 ng/ml **
- |
25 ul serum, whole blood |
quantitative |
| Opiates
(serum/blood) Elisa |
EIA4928 |
30 / 30 min |
5 - 500 ng/ml **
- |
25 ul serum, whole blood |
quantitative |
| Opiates
(urine) Elisa |
EIA4929 |
30 / 30 min |
50 - 1000 ng/ml **
- |
25 ul urine |
quantitative |
| Opiates
(urine) Elisa |
EIA4922 |
30 / 30 min |
50-1000 ng/ml **
--- |
25 ul urine |
quantitative |
| Osteocalcin
(mouse) |
EIA4010 |
18-24h/30/15 min |
1 - 50 ng/ml, quantit / |
5-10 ul serum |
quantitative |
| Osteocalcin
(rat) |
EIA2095 |
|
|
|
quantitative |
| Osteocalcin
intact (human) |
EIA1735 |
3 hrs. at RT |
0.78 ng/ml |
Plasma |
quantitative |
| Osteocalcin
intact EIA |
EIA3375 |
120/30 min. |
2-90 pg/ml |
25 ul serum, plasma |
quantitative |
| Osteocalcin
mid-tact, (human) |
EIA1733 |
2 hrs. at 20 C. |
0.4 ng/ml |
Serum or Plasma |
quantitative |
| Osteopontin
(human) (OPN) |
EIA3116 |
60 / 60 / 30 / 30 min |
2 - 32 ng/mL **
0.11 ng/mL |
100 uL cuture fluids, urine,
breast milk, and plasma EDTA |
quantitative |
| Osteopontin
(mouse, and rat) |
EIA3557 |
|
|
|
quantitative |
| Osteoprotegerin
(human) Elisa |
EIA4573 |
60 / 60 / 30 / 10 min |
1.5 - 60 pmol/l ** 0.13 pmol/l |
50 ul serum, plasma, synovial
fluid and tissue culture medium |
quantitative |
| Osteoprotegerin
(OPG) |
EIA3551 |
|
|
|
quantitative |
| Ovalbumin
IgA Elisa |
EIA4295 |
30 / 30 / 10 min. |
pos. and neg. control |
10 ul serum, plasma (1:100
diluted) |
qualitative |
| Ovalbumin
IgG |
EIA4296 |
30 / 30 / 10 min. |
pos. and neg. control |
10 ul serum, plasma (1:100
diluted) |
qualitative |
| Ovarian
(anti-Ovarian Ab) |
EIA2937 |
60/60/30 min. @ RT |
n/a |
serum |
quantitative |
| Ovarian Ab
Ig-Typing Elisa |
EIA3777 |
|
|
|
quantitative |
| Oxytocin
Elisa |
EIA3117 |
18-24 h 4C / 60 min RT |
3.9-1000 pg/mL ** 4.68 pg/mL |
100 uL tissue cultures media,
incl. those containing fetal bovine serum |
quantitative |
| P |
|
|
|
|
|
| p27, human
p27 (p27Klp1) |
EIA4491 |
609/60/30/30 min |
25 - 1,600 pg/mL **
10.8 pg/mL |
100 uL total cell lysates |
quantitative |
| P38 MAPK
(total) |
EIA4003 |
120/60/30/30 min |
31.2 - 2000 pg/ml /
16 pg/ml |
100 ul cell extract |
quantitative |
| P38 MAPK
[pTpY180/182] Elisa |
EIA4004 |
120/60/30/30 min |
1.6 - 100 U/ml /
0.8 U/ml |
100 ul cell extract |
quantitative |
| p53 total
human Elisa |
EIA4632 |
120/60/30 min RT |
125 - 8000 pg/mL **
<50 pg/mL |
10 ul serum, plasma, buffered
solution, or cell lysates |
quantitative |
| P-ANCA,
Elisa |
EIA2579 |
|
|
|
|
| Pancreatic
Peptide Elisa |
EIA4639 |
2h/1h/1h RT |
0-100 ng/ml **
/ |
50 ul plasma |
qunatitative |
| Pankrin
Elisa |
EIA3781 |
|
|
|
quantitative |
| PAP
(Prostatic Acid Phosphate) |
EIA1566 |
40 min at RT |
1-30 ng/ml |
serum |
quantitative |
| PAP Complex
(Plasmin alpha-2 Antiplasmin Complex) |
EIA3763 |
20'/20'/15' |
50 - 5000 ug/l / 50
ug/l |
plasma 50 ul |
quantitative |
| PAPP-A - 60
Elisa |
EIA4889 |
30/30/15 min |
2.0 - 60.0 ug/ml **
0.034 ug/ml |
20 ul serum, plasma |
qunatitative |
| PAPP-A
(human) <EIA2397(a)> |
EIA2397 |
30/30/15 min |
1.0 - 30.0 ug/ml **
0.133 ug/ml |
10 ul serum, plasma |
quantitative |
| PAPP-A US
(ultra sensitive) Elisa |
EIA4512 |
60 / 60/ 30 / 15 min |
11.25 - 450 ng/ml /
0.023 ng/ml |
100 ul serum |
quantitative |
| Parainfluenza
1,2,3 IgA - |
EIA3871 |
60 min 37 C /
30/15 min. RT |
pos./neg./cut-off control **
>90 % |
10 uL serum |
qualitative |
| Parainfluenza
1,2,3 IgG |
EIA3501 |
60 min 37 C; 30 / 15 min RT |
pos. / neg. control |
10 ul serum (1+100 diluted) |
qualitative |
| Parainfluenza
1/2/3 IgA, Elisa |
EIA4351 |
60 / 30 / 20min. RT |
pos./neg. control ** - |
100 ul serum, plasma (diluted
1:101) |
qualitative |
| Parainfluenza
1/2/3 IgG Elisa |
EIA4349 |
60 / 30 / 20 min. RT |
pos./neg. control ** - |
100 ul serum, plasma (diluted
1:101) |
qualitative |
| Parainfluenza
1/2/3 IgM, Elisa |
EIA4350 |
60 / 30 / 20 min RT |
pos./neg control ** - |
100 ul serum, plasma (diluted
1:101) |
qualitative |
| Parainfluenza
3 (PI3) Bovine Elisa |
EIA4429 |
60/60 min 37 C; 10 min RT |
pos. samples; qualitative test |
10 ul bovine serum |
qualitative |
| Parainfluenza
Virus-5 (PI5) IgG antibodies (dog) |
EIA2491 |
60/60/20 min. |
Positive and Negative Control |
100 ul Serum (3-fold diluted, 1:30
- 1:810) |
|
| Parietal
cell, anti- Elisa |
EIA3607 |
|
|
|
quantitative |
| Parvovirus
B 19 IgG |
EIA3503 |
60 min 37 C; 30 / 15 min. RT |
pos./ neg. / cut off control |
10 ul serum (1+100 diluted) |
qualitative |
| Parvovirus
B 19 IgM |
EIA3504 |
60 min 37 C; 30 / 15 min. RT |
pos. / neg. / cut off control |
10 ul serum (1+100 diluted) |
qualitative |
| Parvovirus
IgG (w/o controls) |
EIA4328 |
|
|
|
quantitative |
| Parvovirus
IgM (w/o controls) |
EIA4329 |
|
|
|
quantitative |
| PCP
(phenyclidine) |
EIA1515 |
|
|
|
|
| PCP
(phenyclidine) |
EIA2904 |
|
|
|
quantitative |
| Pepsinogen
I Elisa |
EIA4604 |
60 / 20 min |
3 - 300 ng/ml
** 0.5 ng/ml |
25 ul serum |
quantitative |
| Pepsinogen
II Elisa |
EIA4603 |
120 / 20 min |
6.3 - 100 ng/ml **
0.5 ng/ml |
50 ul serum |
quantitative |
| PGF2-alpha
(8-iso-PGF2-alpha ) |
EIA3080 |
120 / 45 min |
6.1 - 100,000 pg/mL ** 16.3 pg/mL |
100 uL biological fluids |
quantitative |
| Phenylalanine
(with Membrane Plate) |
EIA1479 |
105 min at RT |
0.2 mg/dL |
blood |
quantitative |
| Phenylalanine
(without Membrane Plate) |
EIA1480 |
105 min. at RT |
0.2 mg/dl. |
blood |
quantitative |
| Phenylalanine
neonate (with Membrane Plate) |
EIA1477 |
105 min at RT |
0.2 mg/dL |
blood |
quantitative |
| Phenylalanine
neonate (without Membrane Plate) |
EIA1478 |
105 min at RT |
0.2 mg/dL |
blood |
quantitative |
| Phosphatidic
Acid IgG/IgM, anti Elisa |
EIA3594 |
|
|
|
quantitative |
| Phosphatidyl
Inositol IgG/IgM, anti- Elisa |
EIA3593 |
|
|
|
quantitative |
| Phosphatidyl
Serine Ab IgG/IgM, Elisa |
EIA2580 |
|
|
|
|
| Phosphatidyl
Serine IgG/IgM, anti- Elisa |
EIA3592 |
|
|
|
quantitative |
| Phospho-ERK
1/2 Elisa |
EIA4178 |
60/60/30/30 min. |
62.5-2,000 pg/mL ** 46.5 pg/mL |
100 ul cell lysis matrices and
buffers |
quantitative |
| Phospholipid
Screen IgG/IgM, anti- Elisa |
EIA3591 |
|
|
|
quantitative |
| PIIANP
Elisa (Type IIA Collagen N-Propeptide) |
EIA4446 |
120 / 30 / 30 min |
4.69 - 150 ng/ml **
1.076 ng/ml |
50 ul serum |
quantitative |
| PLGF
(Placenta like growth factor) |
EIA4529 |
60/60/30/30 min |
0-1000 pg/ml **
2,258 pg/ml |
urine / serum |
quantative |
| PLTP
Acitivity (Plasma phospholipid transfer protein) |
EIA4415 |
30 - 60 min 37 C |
yes /
- |
1 - 3 ul serum / plasma |
qualitative |
| PMN
Elastase (human) Elisa |
EIA4856 |
1 hr / 1 hr / 20 min at RT |
0.156-10 ng/mL **
1.98 ng/mL |
5/10 ul (1:100 dil.) cell cult.,
plasma, exucate, bronchoalveolar lavage, cerebronal |
quantitative |
| PMSG
(Pregnant Mare Serum Gonadotropin) |
EIA1298 |
130 min. at RT |
On Request |
serum |
quantitative |
| PR3
IgG (CANCA) (Proteinase-3) |
EIA2778 |
20, 20, 10 RT |
|
serum, 10uL |
semi-quant. |
| Pregnenolon
Serum Elisa |
EIA4912 |
60 / 30 / 15 min |
0.1 - 25.6 ng/ml **
0.054 ng/ml |
50 ul serum |
quantitative |
| Pregnenolone |
EIA4170 |
60/15/ min |
0,1 - 25,6 ng/ml ** 0.05 ng/ml |
50 ul serum |
quantitative |
| Progesterone |
CLA4656 |
60 / 10 min |
0.1 - 60 ng/ml |
25 ul serum |
quantitative |
| Progesterone |
EIA1561 |
75 min. at RT |
0.3-20 ng/ml |
serum |
quantitative |
| Progesterone |
SLV2931 |
60 / 15 min |
10 - 5000 pg/ml **
5.5 pg/ml |
25 ul saliva |
quantitative |
| Progesterone
(serum) CLA |
CLA4663 |
min |
|
serum |
quantitative |
| Progesterone
/ 17a Hydroxy-Progesterone (serum) CLA |
CLA4665 |
min |
|
serum |
quantitative |
| Progesterone,
17 a-Hydroxy- |
EIA1292 |
90 min. at RT |
0.15-20 ng/ml |
serum (saliva) |
quantitative |
| Progesterone,
17 a-Hydroxy- (Neo Screen) |
EIA1105 |
2 x overnight at RT |
5-250 ng/mL |
blood spot disks |
quantitative |
| Progesterone,
17 a-Hydroxy- (salivary) |
SLV3140 |
60/15 min |
5 - 5000 pg/ml **
3 pg/ml |
25 ul saliva |
quantitative |
| Proinsulin
Control sera, 2 levels, 2 x 1 ml |
EIA2061 |
|
|
|
|
| Proinsulin intact |
EIA1560 |
270 min. at RT. |
2-100 pmol/L |
serum, plasma |
quantitative |
| Proinsulin
total (human) |
EIA4156 |
60/60/30 min |
2 - 200 pM / 0.5 pM |
20 ul serum and plasma |
quantitative |
| Prolactin |
CLA4729 |
30 min |
5-200 ng/ml **
0.3 ng/ml |
25 ul serum` |
quantative |
| Prolactin |
EIA1291 |
40 min. at RT |
5-200 ng/ml |
serum |
quantitative |
| Prolactin
(rat) Elisa |
EIA4493 |
180 / 30 min |
2.25 - 180 ng/ml **
0.36 ng/ml |
10 uL serum / plasma |
quantitative |
| Prostacyclin
(urinary Prostacycline) |
EIA3108 |
|
|
|
quantitative |
| Prostaglandin
(6-keto) F1 (alpha) |
EIA3078 |
|
|
|
quantitative |
| Prostaglandin
E1 |
EIA3092 |
|
|
|
quantitative |
| Prostaglandin
E2, High Sensitivity |
EIA3097 |
|
|
|
quantitative |
| Prostaglandin
E2, High Sensitivity |
EIA3525 |
|
|
|
quantitative |
| Prostaglandin
F2 (alpha) |
EIA3101 |
|
|
|
quantitative |
| Prostaglandin
J2, 15-deoxy- 12,14-, correlate EIA |
EIA3640 |
|
|
|
quantitative |
| Prostaglandin
J2, 15-deoxy-, Correlate-EIA (5 x 96
wells) |
EIA3540 |
|
|
|
quantitative |
| Protein A |
EIA1823 |
3 hrs. |
<1pg/ml / 13.6 pg/ml |
serum |
quantitative |
| Prothrombin
IgG, anti- Elisa |
EIA3613 |
|
|
|
quantitative |
| Prothrombin
IgG/IgM, anti- Elisa |
EIA3612 |
|
|
|
quantitative |
| Prothrombin
Screen, anti- |
EIA3614 |
|
|
|
quantitative |
| PSA
(Prostate Specific Antigen) |
EIA1778 |
2 hrs. at RT |
0.5 ng/ml |
serum |
quantitative |
| PSA
(Prostate Specific Antigen) |
EIA4105 |
|
|
|
quantitative |
| PSA free |
EIA1792 |
2 hrs. at RT |
0.05 ng/ml |
serum |
quantitative |
| PSA free |
EIA4189 |
60/60/15 min |
0.75 - 12 ng/ml /
0.1 nng/ml |
25ul serum |
quantitative |
| PSA total |
EIA3719 |
1.5 hrs |
1.56 - 25 ng/ml / 0.5 ng/ml |
25 ul |
quantitative |
| PSA, Total |
EIA3945 |
|
|
|
quantitative |
| PSA, Total
(Prostate Specific Antigen) |
CLA4657 |
30 / 30 / 10 - 15 min. |
0.005 - 100 ng/ml **
0.002 ng/ml |
50 ul serum |
quantitative |
| PTH Intact
(Parathyroid Hormone) |
EIA3645 |
3 hrs |
.9 pg/ml |
human serum |
quantitative |
| PTH-RP
(1-34) (human, rat, mouse) Elisa |
EIA4757 |
2h/ 1h/ 1h RT |
0-100 ng/ml **
- |
50 ul plasma |
quantitative |
| PYY (human)
Elisa |
EIA4480 |
overnight / 120/30 min |
50 - 10000 pg/ml **
- |
25 uL plasma |
quantitative |
| PYY (rat)
Elisa |
EIA4473 |
overnight / 120 / 30 min |
50 - 20000 pg/ml ** - |
25 uL plasma |
quantitative |
| R |
|
|
|
|
|
| Rabies IgG
(dog) Ab, virus |
EIA2486 |
|
Positive and Negative Control |
|
|
| Rabies IgM
(dog) Ab, virus |
EIA2487 |
|
Positive and Negative Control |
|
qualitative |
| Rabies
Virus (dog) Ag, Nucleo |
EIA2490 |
|
Positive and Negative Control |
|
|
| Rabies
Virus Ag, Glycoprotein |
EIA2489 |
|
Positive and Negative Control |
|
|
| RANTES
(rat) |
EIA3785 |
4h |
39-2500 pg/ml < 20 pg/ml |
25 ul |
quantitative |
| Resistin
(51-108) (human) |
EIA3705 |
|
0.1 - 800 ng/ml |
Serum |
quantitative |
| Resistin
(human) |
EIA4194 |
90/60/30 min |
0,16 - 10 ng/ml 0,16 ng/ml |
20 ul serum/plasma bioligical
Media (dilution 1:10) |
quantitative |
| Resistin
(human) Elisa |
EIA4572 |
60 / 60 / 60 / 10 min |
1 - 50 ng/ml **
0.033 ng/ml |
10 ul serum, plasma and tissue
culture medium |
quantitative |
| Resistin
(mouse) |
EIA4283 |
60 / 60 / 30 / 15 min |
0.78 - 50 ng/ml **
0.78 ng/ml |
10 ul serum, plasma, adipocyte
extracts or cell culture media samples |
quantitative |
| Resistin
(mouse) |
EIA4554 |
60/60/30/10 min. |
1 - 100 ng/ml **
5 pg/ml |
10 ul serum, plasma (EDTA,
citrate) and tissues culture medium |
quantitative |
| Resistin
(rat) Elisa |
EIA4550 |
60/60/30/10 min |
0.25 - 20 ng / ml **
0.05ng/ml |
10 ul serum and tissue culture
media |
quantitative |
| Retinol
binding Protein (RBP) Elisa |
EIA4391 |
1h/ 1h/ 10/20 min. |
1/1 - 33 ug/l ** 0.9 ug/l |
20 ul plasma, serum; 100 ul urine |
quantitative |
| RF IgA
(Rheumatoid Factor), Elisa |
EIA3586 |
|
|
|
quantitative |
| RF IgG
(Rheumatoid Factor), Elisa |
EIA3584 |
|
|
|
quantitative |
| RF
IgG/IgM/IgA (Rheumatoid Factor Screen)
Elisa |
EIA3583 |
|
|
|
quantitative |
| RF IgM
(Rheumatoid Factor) |
EIA2775 |
20, 20, 10 RT |
|
serum, 10 uL |
semi-quant. |
| RF IgM
(Rheumatoid Factor), Elisa |
EIA3585 |
|
|
|
quantitative |
| Rib-P,
anti- Elisa |
EIA3582 |
|
|
|
quantitative |
| Rickettsia
conorii IgM Elisa |
EIA4613 |
60/30/10 min |
pos./neg./cut-off controll |
10 ul serum |
qualitativ |
| RNP-70 Kd,
anti- Elisa |
EIA3579 |
|
|
|
quantitative |
| Rotavirus
Ag (stool) |
EIA3509 |
30 / 5 / 5 / 5 min. |
pos. / neg. control ** 100 % |
stool |
qualitative |
| RSV IgA
(Respiratory syncytial virus) |
EIA3506 |
60 min. 37 C; 30 / 15 min. RT |
pos. / neg. control |
10 ul serum (1+100 diluted) |
qualitative |
| RSV IgG
(Respiratory syncytial virus) |
EIA3507 |
60 37 min C; 30 / 15 min. RT |
pos. / neg. control |
10 ul serum (1+100 diluted) |
qualitative |
| RSV IgM
(Respiratory syncytial virus) |
EIA3508 |
60 min. 37 C; 30 / 15 min. RT |
pos. / neg. / cut off control |
10 ul serum (1+100 diluted) |
qualitative |
| Rubella IgG |
EIA1800 |
90 min at RT |
|
serum |
quantitative |
| Rubella IgG
quant. |
EIA3510 |
60 min 37 C; 30 / 15 min. RT |
pos. / neg. control |
10 ul serum (1+100 diluted) |
quantitative |
| Rubella IgM |
EIA1801 |
90 min at RT |
|
serum |
quantitative |
| Rubella IgM |
EIA3511 |
60 min 37 C; 30 / 15 min. RT |
pos. / neg. / cut off control |
10 ul serum (1+100 diluted) |
qualitative |
| S |
|
|
|
|
|
| S100 Elisa |
EIA4556 |
120/60/30 min |
50 - 3500 ng/L **
<10 ng/L |
50 uL serum |
quantitative |
| S100B
(human) Elisa |
EIA4555 |
90/90/10 min |
50 - 2000 pg/ml **
5 pg/ml |
60 ul serum, liquor, plasma and
tissue cultur |
quantitative |
| Saliva
Control |
SLV4576 |
|
|
|
|
| sApo1/FAS
(human) Elisa |
EIA4854 |
1 hr / 1 hr / 10 min at 37C |
16-1000 pg/mL **
13.2 pg/mL |
50 ul cell culture, serum, plasma,
other body |
quantitative |
| sCD23
(human) Elisa |
EIA4833 |
2 hrs / 1 hr / 10 min. at RT |
12.5 - 400 U/mL **
6.789 U/mL |
100 ul cell culture, serum, plasma
other biol |
quantitative |
| sCD30
(human) Elisa |
EIA4849 |
3 hrs/ 10 min. at RT |
1.6 - 100 ng/mL **
0.33 ng**mL |
25 ul cell culture supernatant,
serum, plasma |
quantitative |
| sCD40
(human) Elisa |
EIA4850 |
2 hrs / 1 hr / 10 min at RT |
8 - 500 pg/mL **
7.92 pg/mL |
50 ul cell culture supernatant,
other body fl |
quantitative |
| sCD40
Ligand (human) Elisa |
EIA4852 |
2 hrs at RT shaking or overnight
at 4C / 10 min |
0.16 - 10 pg/mL **
0.062 pg/mL |
20 ul cell culture, serum, plasma |
quantitative |
| sCD40
Ligand (human) high sensitive Elisa |
EIA4851 |
2 hrs / 1 hr / 10 min |
0.08 - 5.0 ng/mL **
0.01 ng/mL |
20 ul cell culture supernatant,
serum and plasma (EDTA, citrate, heparinized) |
quantitative |
| sCD44
(human) Elisa |
EIA4876 |
3 hrs/ 15 min. at RT |
0.12-4ng/m. **
0.015 ng/mL |
10 ul cell culture supernatant,
other body fl |
quantitative |
| Schistosoma
IgG |
EIA3512 |
10 / 10 / 5 min. |
pos. / neg. control ** - |
100 ul serum (diluted 1:40) |
|
| Scl-70,
anti- Elisa |
EIA3580 |
|
|
|
quantitative |
| Secretory
IgA (sIgA) Elisa |
EIA4601 |
60 / 60 / 5 - 15 min RT |
22.2 - 600 ng/ml **
13.4 ng/ml |
10 ul saliva + 100 mg stool |
quantitative |
| Serotonin |
EIA1300 |
18 hrs |
0.14-33 ng/ml |
plasma or urine |
quantitative |
| Serotonin |
EIA3947 |
60 / 30 / 20 min. RT |
15-2500 ng/ml ** 7.5 ng/ml Erum,
Urin, 3ng /ml |
10 ul Serum, Urin, 25 ul Plasma,
20 ul Cellhomog., 50 ul Liquor |
quantitative |
| Serotonin
Research (ultra sensitive) |
EIA4642 |
30/min/15-20h 2-2C/30/20-30min |
2-333 pg ** 1 pg |
20 ul tissue homogenates,
dialysates and oth. ultra small sample volumes |
quantitative |
| Serum
Amyloid A (SAA) Multispecies Elisa |
EIA4450 |
60 min 37C; 30/30 min. RT |
1.25 - 2000 ng/ml (depends on
species) |
50 uL diluted serum, plasma, milk
or cell culture supernatant |
quantitative |
| sE-Selectin
Elisa |
EIA4775 |
2 hrs / 15 min. at RT |
1.6 - 50 ng/ml **
0.33 ng/mL |
20 uL serum, plasma, cell culture
and other bioligical fluids |
quantitative |
| sFAS Ligand
(human) Elisa |
EIA4855 |
2 hrs / 1 hr / 10 min. at RT |
0.16 - 10 ng/mL **
0.07 ng/mL |
50 ul cell culture, serum, plasma,
amniotic fluid |
quantitative |
| sGP130/sCD130
(human) Elisa |
EIA4768 |
60/30/10 - 15 min |
56.25 - 1800 pg/mo **
<15 pg/ml |
100 ul cell culture supernatants,
human serum |
quantitative |
| SHBG (Sex
Hormone Binding Globulin) IEMA |
EIA2996 |
30 / 15 / 12 min |
4 - 260 nmol/l **
0.2 nmol/l |
25 uL serum / plasma |
quantitative |
| sICAM-1
(human) |
EIA4781 |
60 / 10 min |
6.25 - 100 ng/ml - **
2.17 ng/mL |
10 uL cell cult. supern., serum,
plasma, urine |
quantitative |
| SLE
(anti-Nucleosomes) Elisa |
EIA3610 |
|
|
|
quantitative |
| sL-selectin
human Elisa |
EIA4875 |
2 hrs/ 15 min. at RT |
0.39-25ng/ml **
0.19 ng/mL |
5 ul cell culture supernatant,
other body fluids |
quantitative |
| Sm anti-,
Elisa |
EIA3577 |
|
|
|
quantitative |
| Sm IgG |
EIA2784 |
20, 20, 10 RT. |
|
serum, 10 uL |
semi-quant. |
| Sm RNP IgG |
EIA2785 |
20, 20, 10 RT |
|
serum, 10uL |
semi-quant. |
| Sm RNP,
anti-RNP Elisa |
EIA3578 |
|
|
|
quantitative |
| Soya IgA
Elisa |
EIA4300 |
30 / 30 / 10 min. |
pos. and neg. control |
10 ul serum, plasma (1:100
diluted) |
qualitative |
| Soya IgG
Elisa |
EIA4299 |
30 / 30 / 10 min |
pos. and neg. control |
10 ul serum, plasma (1:100 dilutes |
qualitative |
| sp185
(HER-2) human Elisa |
EIA4877 |
2 hrs/ 10 min. at RT |
0.16-10ng/ml **
0.06 ng**mL |
15 ul cell culture supernatant,
other body fluids |
quantitative |
| Sperm Ab
Ig-Typing Elisa |
EIA4878 |
60/60 min 37 C, 30 min RT |
31-250 U/mL **
--- |
5 uL serum |
quantitative |
| Sperm
Antibody |
EIA1826 |
3 hrs. |
62-500 U/ml |
serum |
quantitative |
| Sperm
Antibody |
EIA4249 |
60/60 min 37 C; 30 min. RT |
31 - 250 U/ml ** - |
50ul dil. seminal plasma (dil. 100
ul ejaculate w. 400 ul dil. buffer) |
quantitative |
| sPJ-selectin
human, Elisa |
EIA4874 |
2 hrs/ 15 min. at RT |
2.19-140 ng/ml **
1.06 ng/mL |
10 ul cell culture supernatant,
other body fl |
quantitative |
| sPLA2
Activity kit (secretory Phospholipase
A2) |
EIA3636 |
|
|
|
|
| sRANKL
(free) human Elisa |
EIA4771 |
2h/ 1h/1h/10 min RT |
0.4 - 40 pmol/l **
0.2pmol/l |
5 ul serum / plasma |
quantitative |
| sRANKL
(total) human Elisa |
EIA4772 |
16h 4/6C; 1h/1h/10min RT |
0.4 - 64 pmol/l **
0.1pmol/l |
5 ul serum / plasma |
quantitative |
| SS-A (Ro)
IgG |
EIA2782 |
20, 20, 10 RT. |
|
serum, 10 uL |
semi-quant. |
| SS-A (Ro),
anti- Elisa |
EIA3573 |
|
|
|
quantitative |
| SS-A 52,
anti- Elisa |
EIA3574 |
|
|
|
quantitative |
| SS-A 60,
anti- Elisa |
EIA3575 |
|
|
|
quantitative |
| SSB (La)
IgG |
EIA2783 |
20, 20, 10 RT. |
|
serum, 10 uL |
semi-quant. |
| SS-B (La),
anti- Elisa |
EIA3576 |
|
|
|
quantitative |
| Strongyloides
IgG |
EIA4208 |
10 / 5 / 5 min |
pos. / neg. control ** - |
100 ul serum (diluted 1:64) |
qualitative |
| Substance P |
EIA3120 |
|
|
|
quantitative |
| Substance P
(human - rat - mouse) |
EIA1634 |
4 hrs. at RT |
0.02-0.05 ng/ml |
plasma |
quantitative |
| Survivin
(total) human |
EIA4137 |
60/60/30/30 min. RT |
31.25-1,000 pg/mL **
10.4 pg/mL |
100 uL biolog. fluids |
|
| sVCAM-1
human Elisa |
EIA4873 |
2 hrs/ 15 min. at RT |
3.2-100 ng/ml **
0.59 ng/mL |
10 uL cell culture supernatant,
other body fl |
quantitative |
| Syphilis
(anti-TP) (double antigen sandwich method) |
EIA4131 |
|
|
|
qualitative |
| Syphilis
(Treponema pallidum) Ab |
EIA3798 |
|
|
|
quantitative |
| Syphilis Ab Screen |
EIA4405 |
45/45 min. 37 C; 15 min. RT |
pos. / neg. control, qualit. **
100 % |
10 ul serum; plasma |
qualitative |
| Syphilis IgG/IgM |
EIA1812 |
75 min at 37 C. |
|
serum or plasma |
qualitative |
| T |
|
|
|
|
|
| T-3
(Triiodothyronine) |
EIA1780 |
2 hrs. at RT |
0.2 ng/ml |
serum |
quantitative |
| T-3, Free |
EIA2385 |
|
|
|
|
| T-3, total
Elisa |
EIA4569 |
30/30/20 min. at RT |
0.5 - 10.0 ng/ml **
0.1 ng/ml |
50 ul serum |
quantitative |
| T-3, Uptake |
EIA3267 |
60 / 15 min at RT |
15.0 - 46.0 % U / .. |
25 ul serum or plasma |
quantitative |
| T-4 |
EIA1781 |
1 hr. at RT |
0.4 ug/dl |
serum |
quantitative |
| T-4 (dog) |
EIA2492 |
|
Positive and Negative Control |
|
|
| T-4 (dog)
Rapid EIA |
EIA3441 |
|
|
|
|
| T-4
(feline) Rapid EIA |
EIA3442 |
|
|
|
|
| T-4, free |
CLA4659 |
30 min 27 C / 10/15 min RT |
2 - 120 pg/ml ** 1 pg/ml |
50 ul serum |
quantitative |
| T-4, Free |
EIA2386 |
|
|
|
|
| T-4, Free |
EIA4109 |
|
|
|
quantitative |
| T-4, total
Elisa |
EIA4568 |
5/80 min. at RT, 10 min at 18-25,
7 min 26-29C |
- /
10 nmol/L |
10 ul serum |
quantitative |
| Taenia
Solium IgG (cysticercosis) |
EIA3513 |
10 / 10 / 5 min. |
pos. / neg. control **
88 % |
100 ul serum (diluted 1:64) |
qualitative |
| TAFI
(human) Elisa - thrombin-activatable fibrinolysis inhibitor - |
EIA4606 |
10/60/60/10 min |
0.75 - 48 ng/ml **
- |
20 ul plasma |
quantitative |
| TBEV IgG
(tick borne encephalitis virus) (FSME) |
EIA3515 |
60 min 37 C; 30 / 15 min. RT |
pos. / neg. / cut off control |
10 ul serum (1+100 diluted) |
qualitative |
| TBEV IgM
(tick borne encephalitis virus) (FSME) |
EIA3516 |
60 min. 37 C; 30 / 15 min. RT |
pos. / neg. control |
10 ul serum (1+100 diluted) |
qualitative |
| Testosterone |
EIA1559 |
75 min. at RT |
0.2-16 ng/ml |
serum, plasma |
quantitative |
| Testosterone |
SLV3013 |
60 / 30 min |
10 - 5000 pg/ml **
1.9 pg/mL |
100 ul saliva |
quantitative |
| Testosterone
(serum) CLA |
CLA4662 |
min |
|
serum |
quantitative |
| Testosterone,
(Dihydro-) ELISA |
EIA2330 |
1 hour @ RT |
6 pg/ml |
serum, plasma |
quantitative |
| Testosterone,
(Dihydrotestosterone) |
EIA4132 |
|
|
|
quantitative |
| Testosterone,
11-keto Testosterone (strip plate) |
EIA4526 |
18 h 4C, 60 min. RT |
7.8 - 1000 pg/mL **
1.3 pg/ml |
500 uL serum, plasma |
|
| Testosterone,
free |
CLA4660 |
30 min 37 C / 10 - 15 min |
0.25 - 100 pg/ml **
0.17 pg/ml |
25 ul serum |
quantitative |
| Testosterone,
Free |
EIA2924 |
1 hour @ RT |
0.15 pg/ml |
serum / plasma |
quantitative |
| Testosterone,
Saliva |
CLA4661 |
30 / 30 / 10 - 15 min |
2 - 800 pg/ml ** 1.0 pg/ml |
100 ul saliva |
quantitative |
| Tetanus
toxin IgG (quant.) |
EIA3514 |
60 min 37 C; 30 / 15 min. RT |
2 x pos. control (0.5+5 IU/ml)/ 1
x neg. control |
10 ul serum (1+100 diluted) |
quantitative |
| TGF beta 1
(human) (Transforming Growth Factor) |
EIA1864 |
16-24 hrs at 4 C or RT, total
inc.time :7hrs |
20 - 600 pg/ml; 10pg/ml
sensitivity |
serum/plasma |
quantitative |
| TGF beta 2
(human) (Transfornimg Growth Factor) |
EIA2396 |
|
|
|
quantitative |
| ThromboCombo
IgG / IgM |
EIA3883 |
60'RT |
IgG: 0-100U/mL, IgM: 0-100
U/ml --- |
10 ul serum or plasma |
quantitative |
| Thromboxane
B2 |
EIA3105 |
|
|
|
quantitative |
| Thyroglobulin |
EIA4126 |
|
|
|
quantitative |
| Thyroglobulin
Ab |
EIA3708 |
30/15/15/5 min |
0 - 9000 IU/ml / 10 IU/ml |
10 ul serum plasma |
quantitative |
| Thyroglobulin
anti- |
EIA1613 |
2 hrs at 37 C. |
on request |
serum |
quantitative |
| Thyroglobulin
Anti-Thyroglobulin |
EIA4110 |
|
|
|
quantitative |
| Thyroglobulin
Elisa |
EIA3377 |
|
|
|
quantitative |
| Thyroglobulin
IgG |
EIA2792 |
20, 20, 10 RT |
|
serum, 10uL |
qualitative |
| TIMP-1
Elisa (Tissue Inhibitor of Matrix Metalloproteinase-1) |
EIA3782 |
120/30/30 min RT |
1.56-25 ng/ml < 1ng/ml |
50 uL serum, plasma, buffered
solution, or celll culture medium |
quantitative |
| TNF (alpha)
(rat) |
EIA4774 |
120 / 60 / 15 min |
39 - 2500 pg/ml **
11.2 pg/ml |
50 ul cell cultures supernatants,
human serum |
quantitative |
| TNF alpha
(human) (Tumor Necrosis Factor ) |
EIA0976 |
3 hrs. at 37 C. |
8.3 pg/ml |
serum, plasma, cell culture |
quantitative |
| TNF alpha
(mouse) (Tumor Necrosis Factor) |
EIA1568 |
285 min. at RT |
25-1000 pg/ml |
serum |
quantitative |
| TNF alpha
(mouse) Elisa |
EIA3158 |
90 / 30 / 30 min |
19.5 - 1250 pg/mL ** <3 pg/mL |
50 ul serum, plasma / 100 uL
buffered solution |
quantitative |
| TNF alpha
(mouse) Elisa |
EIA3167 |
2.5 hrs. in total |
19-2000 pg/ml |
50ul Serum, Plasma |
quantitative |
| TNF alpha
(porcine) |
EIA3186 |
Incubation time: 4 hours |
15.6 - 1000 pg/ml |
50 ul serum, plasma, cell culture
samples + 50 ul diluent |
quantitative |
| TNF alpha
(porcine) |
EIA3187 |
Incubation time: 4 hours |
15.6 - 1000 pg/ml |
50 ul serum, plasma, cell culture
samples + 50 ul diluent |
quantitative |
| TNF alpha
(rat) (Tumor Necrosis Factor) Sensitive |
EIA3543 |
|
|
|
quantitative |
| TNF alpha
(rat) Elisa |
EIA2358 |
2.5 hrs. in total |
15-1000 pg/ml |
50ml Serum, Plasma |
quantitative |
| TNF alpha
(rat) Elisa |
EIA3168 |
2.5 hrs. in total |
15 1000 plg/ml |
50ml Serum, Plasma |
quantitative |
| TNF alpha
Elisa / CE |
EIA4641 |
120/120/30 min |
7-518 pg/ml **
0.7 pg/ml |
200 ul serum |
quantitative |
| Toxo IgA |
EIA2013 |
60/60/30 min. |
50-400 AE/ml |
100 ul serum, plasma (1:100 dil.) |
quantitative |
| Toxocara
Canis IgG |
EIA3518 |
10 / 10 / 5 min. |
pos. / neg. control **
93.3 % |
100 ul serum (diluted 1:64) |
qualitative |
| Toxoplasma
gondii IgA Elisa |
EIA3683 |
1h/30 min. |
|
serum |
quantitative |
| Toxoplasma
gondii IgG (quantitative) |
EIA3519 |
60 min 37 C; 30 / 15 min. RT |
20 - 200 IU/ml + neg. control |
10 ul serum (1+100 diluted) |
quantitative |
| Toxoplasma
gondii IgM |
EIA3520 |
60 min 37 C; 30 / 15 min. RT |
pos./ neg. / cut off control |
10 ul serum (1+100 diluted) |
qualitative |
| Toxoplasma
IgG (TORCH) |
EIA1798 |
90 min at RT |
|
serum |
quantitative |
| Toxoplasma
IgM (TORCH) |
EIA1799 |
90 min at RT |
|
serum |
quantitative |
| TPO
(Thyroid Peroxidas) Anti-TPO |
EIA4114 |
|
|
|
quantitative |
| TPO
(Thyroid Peroxidase) anti- Elisa |
EIA3561 |
30 / 15 / 15 min |
33 - 3000 IU/mL **
5 IU/mL |
10 ul serum / plasma |
quantitative |
| TPO IgG
(Thyroid Peroxidase) |
EIA2791 |
20, 20, 10 RT |
|
serum, 10uL |
qualitative |
| TPS
(CYK18) (Tissue Polypeptide Specific
Ag) (Cytokeratin) Elisa |
EIA2354 |
|
|
|
quantitative |
| TRAIL
(human) Elisa |
EIA4009 |
120/60/30/30 min |
46.8 - 3000 pg/ml - quant. / <20 pg/ml |
100 ul cell extract |
quantitative |
| Transferrin
Receptor (sTfR) human Elisa (Soluble) |
EIA4256 |
60 / 60 min. 30 C; 10 min RT |
0.2 - 10 ug/mll ** 0.1 ug/ml |
30 ul serum, plasma and tissued
culture medium |
quantitative |
| Transglutaminase
= t-Transglutaminase-Ab IgA Elisa |
EIA4259 |
30 / 30 / 30 min. |
1 - 100 U/ml ** <0.1 U/ml |
10 ul serum (diluted 1/100) |
quantitative |
| Transglutaminase
= t-Transglutaminase-Ab IgG Elisa |
EIA4260 |
30 / 30 / 30 min. |
1 - 100 U/ml ** <0.1 U/ml |
10 ul serum (diluted 1/100) |
quantitative |
| Transglutaminase
IgA, anti- |
EIA3611 |
|
|
|
quantitative |
| Transglutaminase
IgA, anti- ELISA |
EIA3152 |
60 min. at 4C / 60 min. at RT / 10
min at RT |
positive and negative Reference
sera |
100 ul serum ( 1:250 diluted) |
qualitative |
| Transglutaminase
IgG, anti-tissue |
EIA3882 |
30'/15' RT |
1U/ml |
10 ul serum or plasma |
quantitative |
| Transglutaminase
Screen, anti-tissue Elisa |
EIA4464 |
30 / 15 / 15 min |
5 - 200 U/ml **
1 U/ml |
10 ul serum / plasma |
quantitative |
| Treponema
Pallidum IgG (Syphilis IgG) |
EIA3517 |
60 min 37 C; 30 / 15 min. RT |
pos. / neg. control |
10 ul serum (1+100 diluted) |
qualitative |
| Treponema
Pallidum IgM (Syphilis) |
EIA4267 |
60 37C; 30 / 15 min. RT |
pos. / neg. control |
10 ul serum (1+100 diluted) |
qualitative |
| Treponema
Pallidum Screen Elisa |
EIA4697 |
60/30/15 min at RT |
pos. / neg./ cut-off control ** - |
100 ul Serum, Plasma |
qualitative |
| Tricat
(Adrenalin, Noradrenalin, Dopamine) Elisa |
EIA4634 |
30/20/120/60/40 min |
Adrenalin / Noradrenalin /
Dopamin |
500 ul plasma, 20 ul urine |
quantitative |
| TriCat
Elisa (Adrenaline/Noradrenaline/Dopamine) |
EIA4080 |
30/120/15 min. |
Adr: 10-2560 pg/ml , Noradr:
40-10240 pg/ml |
Plasma and Urine |
quantitative |
| TriCat
Research Elisa (Adren. / Noradren./ Dopamine) |
EIA4891 |
90 min Acylation / 2h 37C/15-20 h
2-8C |
0.45 - 45 ng/ml/ 0.9-90ng/ml
(Dop) ** 0.3 |
1-750 uL; for various biological
samples type |
quantitative |
| Trichinella
spiralis Ab (pig) Elisa |
EIA4838 |
10 / 10 / 10 min |
pos. / neg. control |
swine sera, plasma, shole blood or
tissue fluid |
qualitative |
| Trichinella
spiralis IgG |
EIA3521 |
10 / 5 / 5 min. |
pos. / neg. control **
96.3 % |
100 ul serum (diluted 1:64) |
qualitative |
| Tricyclics |
EIA1518 |
45 min. at RT |
|
serum, plasma, blood |
quantitative |
| Troponin I
Elisa |
EIA2952 |
|
|
serum |
quantitative |
| Trypsin
Neonate |
EIA1278 |
75 min. at RT |
|
|
quantitative |
| TSH |
CLA4658 |
30 / 10 - 15 min |
0.008 - 25 ulU/ml **
0.002 ulU/ml |
50 ul serum |
quantitative |
| TSH
(neonatal) (Thyroid Stimulating Hormone) |
EIA1483 |
75 min. RT |
|
|
quantitative |
| TSH
(Thyroid Stimulating Hormone) |
EIA1782 |
80 min. at RT |
0.2 uIU/ml |
serum |
quantitative |
| TSH
(Thyroid Stimulating Hormone) |
EIA4111 |
|
|
|
quantitative |
| TSH
receptor Ab Elisa (3rd Generation) |
EIA4834 |
2h / 25 min |
0.4 - 30 units./L **
/ |
75 ul serum |
quantitative |
| TSH
Receptor Autoantibody Elisa (TRAb) |
EIA3369 |
2 hrs/20/20/20 min. at RT |
negative/positive control |
100 ul serum |
qualitative |
| TSH
Ultrasensitive |
EIA1790 |
4 hrs. at RT |
0.05 uIU/ml |
serum |
quantitative |
| TSH, Elisa |
EIA4171 |
10/90/20 min. RT |
0-15 mlU/l ** 0.027 mlU/L |
25 ul serum |
quantitative |
| Tuberculosis
IgA |
EIA4250 |
60 / 30 / 20 min. RT |
ps. / neg. control |
100 ul serum, plasma (diluted
1:101) |
qualitative |
| Tuberculosis
IgG |
EIA4252 |
60 / 30 / 20 min. RT |
pos. / neg. control |
100 ul serum, plasma (diluted
1:101) |
qualitative |
| Tuberculosis
IgG sensitive Elisa |
EIA4508 |
60 / 30 / 20 min. RT |
1 - 150 U/ML / / |
100 ul serum, plasma (diluted
1:101) |
quantitative |
| Tuberculosis
IgM |
EIA4251 |
60 / 30 / 20 min. RT |
pos. / neg. control |
100 ul serum, plasma (diluted
1:101) |
qualitative |
| Tumor
Marker Control I (1 vial, 0.5 ml lyophilized) |
CTL4756 |
|
|
|
|
| Tumor
Marker Control II (1 vial, o.5 ml lyophilized) |
CTL4755 |
|
|
|
|
| U |
|
|
|
|
|
| UBC
(Urinary Bladder Cancer) Elisa |
EIA2355 |
|
|
urine |
quantitative |
| Ureaplasma
urealyticum IgG Elisa |
EIA4623 |
60 / 60 / 20 min at RT |
pos./neg./cut-off control |
10 ul serum, plasma |
qualitative |
| Urotensin
II (human) |
EIA3303 |
2 hrs RT |
0 - 100 ng/mL |
Plasma |
|